{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":2393,"total_is_capped":false,"direct_labels_cover":8,"predictions_cover":2393,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12","author_layer_release":"2026-06-26"},"query_hash":"9ec9f971cebb","filters":{"topic":"Psoriasis: Treatment and Pathogenesis"}},"results":[{"id":"W1973354423","doi":"10.1056/nejmoa1314258","title":"Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1964,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Secukinumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Etanercept; Placebo; Dosing; Dermatology Life Quality Index; Clinical endpoint; Internal medicine; Dermatology; Clinical trial; Psoriatic arthritis; Tumor necrosis factor alpha; Pathology","authors":[{"name":"Richard G. Langley","is_ca":true},{"name":"Boni E. Elewski","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Kristian Reich","is_ca":false},{"name":"C.E.M. Griffiths","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"L. Puig","is_ca":false},{"name":"Hidemi Nakagawa","is_ca":false},{"name":"Lynda Spelman","is_ca":true},{"name":"Bárður Sigurgeirsson","is_ca":false},{"name":"Enrique Rivas","is_ca":false},{"name":"Tsen‐Fang Tsai","is_ca":false},{"name":"Norman Wasel","is_ca":true},{"name":"Stephen K. Tyring","is_ca":false},{"name":"Thomas Salko","is_ca":false},{"name":"Isabelle Hampele","is_ca":false},{"name":"Marianne Notter","is_ca":false},{"name":"Alexander Karpov","is_ca":false},{"name":"Silvia Helou","is_ca":false},{"name":"C. Papavassilis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0397480406814782,"gpt":0.3245614633366991,"spread":0.2848134226552209,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005152814,0.0001751633,0.001150277,0.0003589508,0.0000323035,0.000002767791,0.0001940499,0.0001452249,0.0003539086],"category_scores_gemma":[0.002434563,0.0001066563,0.0001406743,0.0001796838,0.00009934031,0.00006414093,0.00001571279,0.0002576137,0.00001429476],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003084905,"about_ca_system_score_gemma":0.0001108791,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002990473,"about_ca_topic_score_gemma":0.00015384,"domain_scores_codex":[0.9970388,0.001107154,0.001398475,0.0001422431,0.0001000723,0.0002132079],"domain_scores_gemma":[0.9968812,0.001774789,0.0009671404,0.0001926791,0.0001179426,0.00006627512],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0186871,0.0003798433,0.001223088,0.00001964354,0.0005428937,0.00008221628,0.002820261,0.00002663759,0.1385335,0.0003815374,0.01484483,0.8224585],"study_design_scores_gemma":[0.7111362,0.005967327,0.001890494,0.000590279,0.0007661619,0.0007476114,0.0002525582,0.000006321421,0.08858801,0.001945457,0.1879232,0.000186361],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9875407,0.004690532,0.0003804467,0.002584533,0.002715688,0.0001506378,0.00003297452,0.000008929177,0.001895522],"genre_scores_gemma":[0.9965771,0.0006936833,0.0001849469,0.00008970312,0.001866053,0.000001362805,0.00003873804,0.00001038103,0.0005380068],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8222721,"threshold_uncertainty_score":0.4349317,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2116956799","doi":"10.1016/s0140-6736(08)60725-4","title":"Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)","year":2008,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1865,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; Western University","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Clinical endpoint; Internal medicine; Randomization; Randomized controlled trial; Intention-to-treat analysis; Gastroenterology; Dermatology; Tumor necrosis factor alpha; Pathology","authors":[{"name":"Craig L. Leonardi","is_ca":false},{"name":"Alexa B. Kimball","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Newman Yeilding","is_ca":false},{"name":"Cynthia Guzzo","is_ca":false},{"name":"Yuhua Wang","is_ca":false},{"name":"Shu Li","is_ca":false},{"name":"Lisa T. Dooley","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03512843593995436,"gpt":0.2649349371817737,"spread":0.2298065012418194,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005785024,0.0003337308,0.001396456,0.0001336083,0.0002374871,0.00001525063,0.0003690327,0.0002296557,0.00006510349],"category_scores_gemma":[0.00009316697,0.0002002484,0.0001501553,0.0001418435,0.0002948742,0.00008466474,0.00008722505,0.0002764864,0.00003053234],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004133862,"about_ca_system_score_gemma":0.00006924486,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004352602,"about_ca_topic_score_gemma":0.0002796588,"domain_scores_codex":[0.9976799,0.0005800234,0.0007848447,0.0004408619,0.0001001722,0.0004141981],"domain_scores_gemma":[0.9980273,0.0008687102,0.000442709,0.0005706814,0.00005903423,0.00003153253],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9830977,0.0009460687,0.009174861,0.000006738841,0.001176676,0.00001292046,0.002622243,0.00001282983,0.001632403,0.00003200585,0.0004069151,0.0008785831],"study_design_scores_gemma":[0.9242233,0.001328702,0.07190811,0.00009832269,0.0003439263,0.000007872626,0.00006035647,0.000001986523,0.00138032,0.00002667174,0.0004076854,0.0002127574],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943256,0.0005152328,0.000005900259,0.0001211242,0.0004239063,0.003414759,0.0003337445,0.00004247384,0.0008172201],"genre_scores_gemma":[0.9978598,0.0001653598,0.00006087862,0.0000385483,0.0002422561,0.0001972492,0.00095759,0.00002363328,0.000454694],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06273325,"threshold_uncertainty_score":0.8165891,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2004774344","doi":"10.1016/j.chom.2008.09.009","title":"Specific Microbiota Direct the Differentiation of IL-17-Producing T-Helper Cells in the Mucosa of the Small Intestine","year":2008,"lang":"en","type":"article","venue":"Cell Host & Microbe","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1748,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"National Center for Research Resources; National Institute of Allergy and Infectious Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; National Cancer Institute; Howard Hughes Medical Institute","keywords":"Biology; FOXP3; Lamina propria; Immunology; RAR-related orphan receptor gamma; Cellular differentiation; Microbiology; Cell biology; Immunity; Gut flora; Inflammation; Cell; Intestinal mucosa; Effector; Immune system; Epithelium; Internal medicine","authors":[{"name":"Ivaylo I. Ivanov","is_ca":false},{"name":"Rosa de Llanos","is_ca":true},{"name":"Nicolas Manel","is_ca":false},{"name":"Keiji Yoshinaga","is_ca":false},{"name":"Daniel B. Rifkin","is_ca":false},{"name":"R. Balfour Sartor","is_ca":false},{"name":"B. Brett Finlay","is_ca":true},{"name":"Dan R. Littman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01989031726558024,"gpt":0.1941146353517765,"spread":0.1742243180861963,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000363401,0.0002492517,0.0003378019,0.00008306031,0.000242104,0.000008991341,0.0006708888,0.0001592095,0.0001670495],"category_scores_gemma":[0.00003010973,0.0001264033,0.0002239343,0.000359601,0.0003822288,0.00003123695,0.0001486927,0.0002583009,0.00007509816],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000346967,"about_ca_system_score_gemma":0.00004815183,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002205676,"about_ca_topic_score_gemma":0.0001046778,"domain_scores_codex":[0.9983706,0.0004844695,0.0004537565,0.0003368735,0.00004291125,0.0003113213],"domain_scores_gemma":[0.9984426,0.0003630222,0.0003083529,0.0008001844,0.00007644248,0.000009328409],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007106649,0.0003528919,0.01089398,0.00002563767,0.00005988771,0.000002583272,0.004472742,0.00000634864,0.9779181,0.000009453992,0.005472952,0.0007142795],"study_design_scores_gemma":[0.0008149853,0.00005784443,0.1173535,0.0000561354,0.00008451162,0.00004104792,0.0002926087,5.685316e-7,0.8699599,0.000005562759,0.01121278,0.0001205842],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911018,0.005812474,0.00001180092,0.0002443993,0.0007417545,0.0005206406,0.0001341628,0.00001504385,0.001417947],"genre_scores_gemma":[0.9959017,0.0006419604,0.00006565714,0.0001054973,0.00005147089,0.00001578974,0.00007631901,0.00002027974,0.003121333],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1079583,"threshold_uncertainty_score":0.5154576,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1998000193","doi":"10.1038/nm1651","title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","year":2007,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1735,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Centre Hospitalier de l’Université de Montréal; University of Alberta; Université de Montréal; Hôpital Notre-Dame","funders":"Canadian Institutes of Health Research","keywords":"Blood–brain barrier; Inflammation; Central nervous system; Multiple sclerosis; Immunology; Granzyme; Biology; Pathogenesis; Granzyme A; In vivo; Medicine; Neuroscience; Immune system; Granzyme B; T cell; CD8; Perforin","authors":[{"name":"Hania Kébir","is_ca":true},{"name":"Katharina Kreymborg","is_ca":false},{"name":"Igal Ifergan","is_ca":true},{"name":"Aurore Dodelet-Devillers","is_ca":true},{"name":"Romain Cayrol","is_ca":true},{"name":"Monique Bernard","is_ca":true},{"name":"Fabrizio Giuliani","is_ca":true},{"name":"Nathalie Arbour","is_ca":true},{"name":"Burkhard Becher","is_ca":false},{"name":"Alexandre Prat","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006146394405878335,"gpt":0.2451548706411168,"spread":0.2390084762352385,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004460867,0.0002030933,0.0002800669,0.0001430617,0.000234752,0.000007472335,0.00009015869,0.0005910062,0.00008111522],"category_scores_gemma":[0.0001056847,0.0001418388,0.00004273182,0.0001324785,0.0001420744,0.00007250008,0.00002497582,0.0002643132,0.00002254205],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008320832,"about_ca_system_score_gemma":0.00002186116,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006139094,"about_ca_topic_score_gemma":0.0000802021,"domain_scores_codex":[0.9989224,0.0001033934,0.0002852351,0.0002694151,0.00006868602,0.0003508648],"domain_scores_gemma":[0.999476,0.00009556741,0.0001269374,0.0001904342,0.00005685467,0.00005419163],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001497788,0.00003519968,0.005219921,0.0001009135,0.000242101,0.00007512464,0.001315308,3.809445e-7,0.9345028,0.00324415,0.0006664213,0.05444794],"study_design_scores_gemma":[0.01098016,0.0008695386,0.4486917,0.0005652025,0.0009437712,0.0008245181,0.001199387,0.000005316881,0.5107293,0.0001997865,0.02455148,0.0004399187],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.985399,0.01106798,0.00004122132,0.0005394155,0.001057821,0.0003246961,0.00001396992,0.0001291952,0.001426692],"genre_scores_gemma":[0.9972311,0.0000411058,0.00004162174,0.0001201358,0.0005811197,0.000009940547,0.0003248643,0.00001577244,0.001634397],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4434718,"threshold_uncertainty_score":0.5784019,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2045113343","doi":"10.1038/ng.311","title":"Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways","year":2009,"lang":"en","type":"article","venue":"Nature Genetics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1396,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland; University of Toronto","funders":"National Center for Research Resources; Foundation for the National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute; National Institutes of Health; National Heart, Lung, and Blood Institute","keywords":"Psoriasis; Biology; Genetics; Single-nucleotide polymorphism; Genome-wide association study; Genetic association; Gene; Epistasis; Immune system; Genetic predisposition; Immunology; Genotype","authors":[{"name":"Rajan P. Nair","is_ca":false},{"name":"Kristina Callis Duffin","is_ca":false},{"name":"Cynthia Helms","is_ca":false},{"name":"Jun Ding","is_ca":false},{"name":"Philip E. Stuart","is_ca":false},{"name":"David E. Goldgar","is_ca":false},{"name":"Jóhann E. Guðjónsson","is_ca":false},{"name":"Yun Li","is_ca":false},{"name":"Trilokraj Tejasvi","is_ca":false},{"name":"Bing Feng","is_ca":false},{"name":"Andreas Ruether","is_ca":false},{"name":"Stefan Schreiber","is_ca":false},{"name":"Michael Weichenthal","is_ca":false},{"name":"Dafna D. Gladman","is_ca":true},{"name":"Proton Rahman","is_ca":true},{"name":"Steven J. Schrodi","is_ca":false},{"name":"Sampath Prahalad","is_ca":false},{"name":"Stephen L. Guthery","is_ca":false},{"name":"Judith Fischer","is_ca":false},{"name":"Wilson Liao","is_ca":false},{"name":"Pui–Yan Kwok","is_ca":false},{"name":"Alan Menter","is_ca":false},{"name":"G.M. Lathrop","is_ca":false},{"name":"Carol A. Wise","is_ca":false},{"name":"Ann B. Begovich","is_ca":false},{"name":"John J. Voorhees","is_ca":false},{"name":"Gerald G. Krueger","is_ca":false},{"name":"A. Bowcock","is_ca":false},{"name":"Gonçalo R. Abecasis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007429858098225966,"gpt":0.2124438266187554,"spread":0.2050139685205295,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002027937,0.0001903855,0.0003093031,0.00009127623,0.0001020206,0.00001068068,0.0001248637,0.0006996754,0.00003381192],"category_scores_gemma":[0.00007257651,0.0001538253,0.00006046738,0.0001728597,0.00004164469,0.00003038063,0.00002247856,0.0002540374,0.00002326657],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006476187,"about_ca_system_score_gemma":0.00004782887,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002473806,"about_ca_topic_score_gemma":0.00002295376,"domain_scores_codex":[0.9990529,0.0001098253,0.0002208574,0.0002661736,0.00007197361,0.0002782671],"domain_scores_gemma":[0.9992742,0.0001177198,0.0002182614,0.0002212607,0.0001398439,0.0000287212],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.000507023,0.0003220973,0.4806135,0.00004334433,0.0009826684,0.00001482514,0.001130599,0.00001908732,0.438894,0.0004700681,0.00316756,0.07383519],"study_design_scores_gemma":[0.001851697,0.0006166921,0.835578,0.0000265903,0.0003322192,0.00001605156,0.00006359869,8.167731e-7,0.1510457,0.0004157678,0.009823499,0.0002293374],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9826751,0.01545405,0.00002820857,0.000261614,0.0003047775,0.00021277,0.0001580161,0.00003561881,0.0008698892],"genre_scores_gemma":[0.9959561,0.001231928,0.0009316897,0.0002439338,0.00007675436,0.000005899388,0.0001857208,0.00001396038,0.001354069],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3549645,"threshold_uncertainty_score":0.6272814,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4248269869","doi":"10.1016/s0140-6736(08)60726-6","title":"Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)","year":2008,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1350,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; Probity Medical Research; Western University","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Placebo; Clinical endpoint; Dosing; Internal medicine; Intention-to-treat analysis; Randomized controlled trial; Adverse effect; Gastroenterology; Immunology; Tumor necrosis factor alpha; Adalimumab","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Richard G. Langley","is_ca":true},{"name":"Mark Lebwohl","is_ca":false},{"name":"Gerald G. Krueger","is_ca":false},{"name":"Philippe Szapary","is_ca":false},{"name":"Newman Yeilding","is_ca":false},{"name":"Cynthia Guzzo","is_ca":false},{"name":"Ming-Chun Hsu","is_ca":false},{"name":"Yuhua Wang","is_ca":false},{"name":"Shu Li","is_ca":false},{"name":"Lisa T. Dooley","is_ca":false},{"name":"Kristian Reich","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03514495136420409,"gpt":0.2649833830382751,"spread":0.229838431674071,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005748423,0.0003340079,0.001398068,0.0001337007,0.0002382007,0.00001508677,0.0003694047,0.0002297975,0.00006515697],"category_scores_gemma":[0.00009311867,0.0002003824,0.0001503044,0.0001420438,0.0002951918,0.00008475603,0.00008731592,0.0002772468,0.00003060422],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004146507,"about_ca_system_score_gemma":0.00006884323,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004406797,"about_ca_topic_score_gemma":0.0003000846,"domain_scores_codex":[0.9976833,0.0005808079,0.0007807677,0.0004400572,0.0001003344,0.0004147274],"domain_scores_gemma":[0.9980275,0.0008700505,0.0004409082,0.0005709821,0.00005898681,0.00003154737],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9828577,0.0009007076,0.009517956,0.000006754829,0.001179865,0.00001282417,0.002614718,0.0000125531,0.001594297,0.00003124425,0.0004195455,0.0008518234],"study_design_scores_gemma":[0.9228213,0.001280397,0.07335903,0.00009691912,0.0003439185,0.000007659906,0.00005917005,0.000001982116,0.00138406,0.00002698255,0.0004059944,0.0002125673],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9942895,0.0005101135,0.000005919872,0.0001213408,0.0004235136,0.003420223,0.0003380645,0.00004251185,0.0008488268],"genre_scores_gemma":[0.9978784,0.0001605863,0.00006087568,0.00003851871,0.0002435549,0.0001973915,0.0009563965,0.0000236445,0.0004406745],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06384108,"threshold_uncertainty_score":0.8171358,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2107730744","doi":"10.1136/ard.2004.033217","title":"Psoriasis: epidemiology, clinical features, and quality of life","year":2005,"lang":"en","type":"review","venue":"Annals of the Rheumatic Diseases","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1107,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Psoriasis; Medicine; Epidemiology; Disease; Psychosocial; Dermatology; Quality of life (healthcare); Pathology; Psychiatry","authors":[{"name":"Richard G. Langley","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.2848710214639295,"gpt":0.4508351941802997,"spread":0.1659641727163703,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00198924,0.0004495631,0.004222676,0.000101996,0.0001030113,0.000004504422,0.0006498717,0.0006593363,0.0001580006],"category_scores_gemma":[0.007028593,0.0002526956,0.001903433,0.0001561727,0.0007917029,0.00004704128,0.0002639442,0.0002705289,0.00005312677],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008310619,"about_ca_system_score_gemma":0.000322277,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000110167,"about_ca_topic_score_gemma":0.00001445097,"domain_scores_codex":[0.9919195,0.004860323,0.002391722,0.0004226189,0.00006218786,0.0003437007],"domain_scores_gemma":[0.9897753,0.006665979,0.002414751,0.0009646911,0.0000916787,0.00008761296],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00009558019,0.0004041954,0.001262242,0.006500404,0.003429407,1.738783e-7,0.00002361642,1.9775e-7,8.594449e-8,0.001003402,0.01359835,0.9736823],"study_design_scores_gemma":[0.001669264,0.0002391047,0.08376278,0.01966537,0.007886483,0.00002425476,0.00006971075,1.724317e-7,0.000006724381,0.001287972,0.8847347,0.0006534734],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001806102,0.9951568,0.000001123314,0.000253831,0.0008140096,0.0005777137,0.001229089,0.00002483238,0.0001365376],"genre_scores_gemma":[0.001655819,0.997049,0.00004032428,0.0001813955,0.00007516851,0.00006071031,0.0002188615,0.00002617076,0.0006925806],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9730289,"threshold_uncertainty_score":0.9999925,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168911501","doi":"10.1016/s0140-6736(05)67763-x","title":"Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial","year":2005,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1069,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; Western University","funders":"Amgen","keywords":"Medicine; Placebo; Psoriasis Area and Severity Index; Etanercept; Psoriasis; Internal medicine; Depression (economics); Physical therapy; Beck Depression Inventory; Adverse effect; Clinical endpoint; Randomized controlled trial; Clinical trial; Psychiatry; Rheumatoid arthritis; Anxiety; Dermatology","authors":[{"name":"Stephen K. Tyring","is_ca":false},{"name":"Alice B. Gottlieb","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Ken Gordon","is_ca":false},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Andrea Wang","is_ca":false},{"name":"Deepa Lalla","is_ca":false},{"name":"Michael Woolley","is_ca":false},{"name":"Angelika Jahreis","is_ca":false},{"name":"Ralph Zitnik","is_ca":false},{"name":"David Cella","is_ca":false},{"name":"Ranga Krishnan","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07492228636010856,"gpt":0.3600600821513356,"spread":0.285137795791227,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001507248,0.0002304206,0.001216059,0.00007290336,0.0001611194,0.00002949504,0.000191239,0.0002961892,0.0001761018],"category_scores_gemma":[0.0001801133,0.0001286521,0.0001526289,0.00006977274,0.0001525269,0.00008105327,0.00006554735,0.0002796251,0.00003801378],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00001547275,"about_ca_system_score_gemma":0.0000283104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003856543,"about_ca_topic_score_gemma":0.0001717056,"domain_scores_codex":[0.9979809,0.0007068386,0.0006059987,0.0003327633,0.00004327893,0.0003302073],"domain_scores_gemma":[0.9981928,0.001199597,0.0001885993,0.0003643896,0.0000188048,0.00003574751],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9405784,0.0003739217,0.009819446,0.000004553953,0.0005447927,0.000004886161,0.0004110147,0.000002406097,0.0005372099,0.00004004275,0.001345526,0.04633782],"study_design_scores_gemma":[0.9898465,0.0002065761,0.005972351,0.00002376097,0.0004400196,0.00001160466,0.00008213853,0.00002440676,0.0004606139,0.00003436249,0.002740391,0.0001572526],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990179,0.004932536,0.00001632495,0.0009504968,0.0007529457,0.00199868,0.00001991599,0.00004780594,0.001102285],"genre_scores_gemma":[0.9959582,0.001595535,0.00007506958,0.0002644302,0.0006204587,0.0002557687,0.00005006793,0.00001337055,0.001167117],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04926814,"threshold_uncertainty_score":0.5246279,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2102889851","doi":"10.1038/ng.2467","title":"Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity","year":2012,"lang":"en","type":"review","venue":"Nature Genetics","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1047,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland; Toronto Western Hospital; University of Toronto; Centre for Addiction and Mental Health","funders":"Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Human Genome Research Institute; National Institute for Health and Care Research; Canadian Institutes of Health Research; Versus Arthritis; Medical Research Council; Wellcome Trust","keywords":"Biology; Genome-wide association study; Innate immune system; Psoriasis; Genetics; Candidate gene; Genetic architecture; Immunology; Immune system; Gene; Computational biology; Phenotype; Single-nucleotide polymorphism; Genotype","authors":[{"name":"Lam C. Tsoi","is_ca":false},{"name":"Sarah L. Spain","is_ca":false},{"name":"Jo Knight","is_ca":true},{"name":"Eva Ellinghaus","is_ca":false},{"name":"Philip E. Stuart","is_ca":false},{"name":"Francesca Capon","is_ca":false},{"name":"Jun Ding","is_ca":false},{"name":"Yanming Li","is_ca":false},{"name":"Trilokraj Tejasvi","is_ca":false},{"name":"Jóhann E. Guðjónsson","is_ca":false},{"name":"Hyun Min Kang","is_ca":false},{"name":"Michael H. Allen","is_ca":false},{"name":"Ross McManus","is_ca":false},{"name":"Giuseppe Novelli","is_ca":false},{"name":"Lena Samuelsson","is_ca":false},{"name":"Joost Schalkwijk","is_ca":false},{"name":"Mona Ståhle","is_ca":false},{"name":"A. David Burden","is_ca":false},{"name":"Catherine Smith","is_ca":false},{"name":"Michael J. Cork","is_ca":false},{"name":"Xavier Estivill","is_ca":false},{"name":"A. Bowcock","is_ca":false},{"name":"Gerald G. Krueger","is_ca":false},{"name":"Wolfgang Weger","is_ca":false},{"name":"Jane Worthington","is_ca":false},{"name":"Rachid Tazi‐Ahnini","is_ca":false},{"name":"Frank O. Nestlé","is_ca":false},{"name":"Adrian Hayday","is_ca":false},{"name":"Per Hoffmann","is_ca":false},{"name":"Juliane Winkelmann","is_ca":false},{"name":"Cisca Wijmenga","is_ca":false},{"name":"Cordelia Langford","is_ca":false},{"name":"Sarah Edkins","is_ca":false},{"name":"Robert Andrews","is_ca":false},{"name":"Hannah Blackburn","is_ca":false},{"name":"Amy Strange","is_ca":false},{"name":"Gavin Band","is_ca":false},{"name":"Richard D. Pearson","is_ca":false},{"name":"Damjan Vukcevic","is_ca":false},{"name":"Chris C. A. Spencer","is_ca":false},{"name":"Panos Deloukas","is_ca":false},{"name":"Ulrich Mrowietz","is_ca":false},{"name":"Stefan Schreiber","is_ca":false},{"name":"Stephan Weidinger","is_ca":false},{"name":"Sulev Kõks","is_ca":false},{"name":"Külli Kingo","is_ca":false},{"name":"Tõnu Esko","is_ca":false},{"name":"Andres Metspalu","is_ca":false},{"name":"Henry W. Lim","is_ca":false},{"name":"John J. Voorhees","is_ca":false},{"name":"Michael Weichenthal","is_ca":false},{"name":"H.‐Erich Wichmann","is_ca":false},{"name":"Vinod Chandran","is_ca":true},{"name":"Cheryl F. Rosen","is_ca":true},{"name":"Proton Rahman","is_ca":true},{"name":"Dafna D. Gladman","is_ca":true},{"name":"C.E.M. Griffiths","is_ca":false},{"name":"André Reis","is_ca":false},{"name":"Juha Kere","is_ca":false},{"name":"Rajan P. Nair","is_ca":false},{"name":"André Franke","is_ca":false},{"name":"Gonçalo R. Abecasis","is_ca":false},{"name":"Richard C. Trembath","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02281824107773177,"gpt":0.2848450931229573,"spread":0.2620268520452255,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0006201837,0.0004364185,0.001270841,0.000152487,0.0001290834,0.000008934606,0.000843181,0.00209751,0.0001881306],"category_scores_gemma":[0.00008183845,0.0002760016,0.0006090352,0.0004194264,0.0002257524,0.00003502357,0.000171991,0.0008207958,0.0001249799],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006598343,"about_ca_system_score_gemma":0.0002777194,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005618956,"about_ca_topic_score_gemma":0.00005735653,"domain_scores_codex":[0.9974254,0.0007974557,0.001000661,0.0003524558,0.0001005334,0.0003235294],"domain_scores_gemma":[0.9969773,0.0002839791,0.001163598,0.001340986,0.0002008752,0.00003324075],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003181087,0.0001904513,0.0001653077,0.001183974,0.001065773,2.173736e-7,0.0003413118,2.587322e-7,0.002267614,0.0003548791,0.000442345,0.993956],"study_design_scores_gemma":[0.000311971,0.00006299841,0.001093794,0.00030663,0.004135247,0.00001228112,0.00004560636,1.089947e-7,0.0343014,0.0003505007,0.9591382,0.0002412342],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004265003,0.9927503,0.000007046628,0.00001664927,0.001656116,0.0007085209,0.0003851294,0.00002377555,0.000187463],"genre_scores_gemma":[0.05855281,0.9394324,0.00006630175,0.00000611732,0.0001998361,0.0000233904,0.0008544605,0.00003597993,0.0008286944],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9937148,"threshold_uncertainty_score":0.9999692,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2172257129","doi":"10.1016/s0140-6736(05)67566-6","title":"Infliximab induction and maintenance therapy for moderate-to-severe psoriasis: a phase III, multicentre, double-blind trial","year":2005,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1045,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Western University; Probity Medical Research","funders":"","keywords":"Infliximab; Psoriasis; Medicine; Psoriasis Area and Severity Index; Placebo; Internal medicine; Gastroenterology; Clinical endpoint; Dermatology; Surgery; Randomized controlled trial; Tumor necrosis factor alpha; Pathology","authors":[{"name":"Kristian Reich","is_ca":false},{"name":"Frank O. Nestlé","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Jean‐Paul Ortonne","is_ca":false},{"name":"Robert J. Evans","is_ca":false},{"name":"Cynthia Guzzo","is_ca":false},{"name":"Shu Li","is_ca":false},{"name":"Lisa T. Dooley","is_ca":false},{"name":"C.E.M. Griffiths","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.06806402176190217,"gpt":0.3177268351608078,"spread":0.2496628133989056,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003118413,0.0002006051,0.0004086743,0.00005442787,0.0002719862,0.00003905226,0.0002007433,0.0001696844,0.00009322914],"category_scores_gemma":[0.000026225,0.0001274786,0.00007727458,0.00009919216,0.00008681079,0.0001192584,0.00003206262,0.0001283742,0.00007715068],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003454432,"about_ca_system_score_gemma":0.0000333388,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004381059,"about_ca_topic_score_gemma":0.00007003425,"domain_scores_codex":[0.9989432,0.0001001868,0.000231468,0.0002962183,0.00003268948,0.0003962504],"domain_scores_gemma":[0.9993498,0.0001189517,0.0001026199,0.0003423893,0.00005814803,0.00002805344],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8012349,0.0004446721,0.00003161569,0.000006147694,0.0004109115,8.189887e-7,0.001851841,0.00004896985,0.00898652,0.000629951,0.01069504,0.1756586],"study_design_scores_gemma":[0.8427601,0.0007300478,0.0001404911,0.00002215152,0.0001329876,0.00002482624,0.0002793405,0.0000706748,0.02815373,0.000227167,0.1272156,0.0002428671],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9902326,0.002388707,0.0002040132,0.003775859,0.0008741861,0.002014787,0.0001010096,0.00007522764,0.0003336077],"genre_scores_gemma":[0.9937463,0.0007217893,0.0004204758,0.0007906977,0.00134525,0.0005794445,0.0001011259,0.0000198912,0.002274956],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1754158,"threshold_uncertainty_score":0.5198426,"prediction_status":"machine_predicted_unvalidated"},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W2108615089","doi":"10.1067/mai.2001.117929","title":"IL-17 is increased in asthmatic airways and induces human bronchial fibroblasts to produce cytokines","year":2001,"lang":"en","type":"article","venue":"Journal of Allergy and Clinical Immunology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":949,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"McGill University; Christie (Canada); Cegep de Sainte Foy","funders":"Medical Research Council Canada; Canadian Lung Association; Medical Research Council; Canadian Thoracic Society","keywords":"Bronchoalveolar lavage; Cytokine; Immunocytochemistry; Immunology; Medicine; Sputum; Chemokine; Eosinophil; Interleukin 8; Peripheral blood mononuclear cell; Interleukin 5; Interleukin; Pathology; Asthma; Inflammation; In vitro; Biology; Lung; Internal medicine","authors":[{"name":"Sophie Molet","is_ca":true},{"name":"Qutayba Hamid","is_ca":true},{"name":"Francis Davoineb","is_ca":true},{"name":"Esra Nutku","is_ca":true},{"name":"Rame Tahaa","is_ca":true},{"name":"Nathalie Pagé","is_ca":true},{"name":"Ron Olivenstein","is_ca":true},{"name":"Jack A. Elias","is_ca":true},{"name":"Jamila Chakir","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02676230942960233,"gpt":0.2977832038162598,"spread":0.2710208943866574,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000646899,0.0002338545,0.0007257009,0.0002607961,0.0001527049,0.00001883347,0.0002246028,0.0004733801,0.0002802007],"category_scores_gemma":[0.000266658,0.0001839956,0.0001399466,0.0001651587,0.0003073752,0.0001677958,0.0001338639,0.0004893623,0.00003417461],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002333606,"about_ca_system_score_gemma":0.00007326876,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001065609,"about_ca_topic_score_gemma":0.0004160854,"domain_scores_codex":[0.9977661,0.0004735945,0.001051613,0.0003153209,0.00004642457,0.000346902],"domain_scores_gemma":[0.99879,0.0004282144,0.0004052906,0.0002051838,0.0001003343,0.0000709963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.01468248,0.004378292,0.1778969,0.000048536,0.008796727,0.0006220858,0.003805753,0.00001198957,0.4403651,0.001109812,0.009947031,0.3383354],"study_design_scores_gemma":[0.008459736,0.005477409,0.9187095,0.0002094133,0.0001620666,0.001226001,0.0004366349,0.00000120894,0.006472536,0.0007449095,0.05775397,0.0003465994],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927304,0.004699546,0.000008012365,0.001482427,0.0005897264,0.0001370968,0.000007586497,0.00001256126,0.0003326492],"genre_scores_gemma":[0.9940611,0.004399572,0.0001645559,0.0004053145,0.0001824864,0.000006169213,0.00001129298,0.00001461599,0.0007548556],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7408127,"threshold_uncertainty_score":0.7503123,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2127834887","doi":"10.1056/nejmoa1109017","title":"Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis","year":2012,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":929,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis Area and Severity Index; Placebo; Psoriasis; Internal medicine; Randomization; Gastroenterology; Body surface area; Clinical endpoint; Dose-ranging study; Interleukin 17; Randomized controlled trial; Immunology; Cytokine; Double blind; Pathology","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Alan Menter","is_ca":false},{"name":"Jean‐Paul Ortonne","is_ca":false},{"name":"James G. Krueger","is_ca":false},{"name":"Gregory Kricorian","is_ca":false},{"name":"Girish Aras","is_ca":false},{"name":"Juan Li","is_ca":false},{"name":"Chris B. Russell","is_ca":false},{"name":"Elizabeth H. Thompson","is_ca":false},{"name":"Scott Baumgartner","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02568001421573626,"gpt":0.2981064434153324,"spread":0.2724264291995962,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.001081723,0.0002223023,0.0006031868,0.0002091241,0.000117238,0.000007512256,0.0002367962,0.0001730716,0.001367932],"category_scores_gemma":[0.000234435,0.0001273207,0.0001530511,0.0001047368,0.0001046814,0.0002551546,0.00001722674,0.0002042482,0.00005148388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004766832,"about_ca_system_score_gemma":0.00007963355,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00005008868,"about_ca_topic_score_gemma":0.00001206155,"domain_scores_codex":[0.9986097,0.0001974023,0.0005371073,0.0001433958,0.00008485146,0.000427492],"domain_scores_gemma":[0.9987457,0.0003458544,0.0003741705,0.0001974787,0.0001614747,0.0001752866],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002262861,0.0003994878,0.0290453,0.00002431798,0.0008387223,0.00001210909,0.003116864,0.0000023017,0.3551346,0.0002508022,0.06660109,0.5423115],"study_design_scores_gemma":[0.07709754,0.004179304,0.02650673,0.0002054049,0.0009161087,0.001319076,0.0006025255,0.000001312953,0.03834253,0.0002042981,0.8503525,0.0002726132],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9755125,0.01257003,0.00120983,0.00181585,0.008065401,0.0002000778,0.00002970826,0.00002627698,0.0005703317],"genre_scores_gemma":[0.9871441,0.0006774374,0.0007836824,0.0002874018,0.007783644,0.000003161885,0.0001537695,0.00002588958,0.00314088],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7837515,"threshold_uncertainty_score":0.999545,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2912058252","doi":"10.1016/j.jaad.2018.11.057","title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":924,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Dermatology; Joint (building); MEDLINE; Intensive care medicine","authors":[{"name":"Alan Menter","is_ca":false},{"name":"Bruce Strober","is_ca":true},{"name":"Daniel H. Kaplan","is_ca":false},{"name":"Darío Kivelevitch","is_ca":false},{"name":"Elizabeth Farley Prater","is_ca":false},{"name":"Benjamin K. Stoff","is_ca":false},{"name":"April W. Armstrong","is_ca":false},{"name":"Cody Connor","is_ca":false},{"name":"Kelly M. Cordoro","is_ca":false},{"name":"Dawn Marie R. Davis","is_ca":false},{"name":"Boni E. Elewski","is_ca":false},{"name":"Joel M. Gelfand","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Alice B. Gottlieb","is_ca":false},{"name":"Arthur Kavanaugh","is_ca":false},{"name":"Matthew Kiselica","is_ca":false},{"name":"Neil J. Korman","is_ca":false},{"name":"Daniela Kroshinsky","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Jason Lichten","is_ca":false},{"name":"Henry W. Lim","is_ca":false},{"name":"Nehal N. Mehta","is_ca":false},{"name":"Amy S. Paller","is_ca":false},{"name":"Sylvia L. Parra","is_ca":false},{"name":"Arun L. Pathy","is_ca":false},{"name":"Reena Rupani","is_ca":false},{"name":"Michael Siegel","is_ca":false},{"name":"Emily Wong","is_ca":false},{"name":"Jashin J. Wu","is_ca":false},{"name":"Vidhya Hariharan","is_ca":false},{"name":"Craig A. Elmets","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08478409348539527,"gpt":0.3482868694989154,"spread":0.2635027760135201,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001713745,0.0004033471,0.003489971,0.0002552954,0.00008116219,0.000002760867,0.0006042269,0.0003031723,0.000007292422],"category_scores_gemma":[0.00003873252,0.0001663483,0.0009904829,0.0002447501,0.0009062805,0.00002594376,0.0001193036,0.0002054576,0.000002122127],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005961237,"about_ca_system_score_gemma":0.000148497,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001921681,"about_ca_topic_score_gemma":0.000002721722,"domain_scores_codex":[0.9974937,0.000461173,0.001490411,0.0002218076,0.00007467611,0.0002582299],"domain_scores_gemma":[0.9934433,0.0007159611,0.005336489,0.0003073137,0.000175735,0.00002116843],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.000605679,0.0001448165,0.000687674,0.003881585,0.0102058,0.00000516252,0.0002375955,0.000005360087,0.0001040853,0.0002747028,0.001188749,0.9826588],"study_design_scores_gemma":[0.002169833,0.001697577,0.0006530205,0.002398321,0.01483523,0.00223983,0.000897214,4.016616e-7,0.00258854,0.00004232381,0.9722669,0.0002108021],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004955328,0.992535,0.00003391897,0.0008465432,0.0003547256,0.001001371,0.0002302593,0.000003774984,0.00003909229],"genre_scores_gemma":[0.005103227,0.9933743,0.00118923,0.00006297466,0.00005000867,0.00004092656,0.00001369248,0.00002549081,0.0001401412],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.982448,"threshold_uncertainty_score":0.6783486,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4211202219","doi":"10.1038/nrdp.2016.82","title":"Psoriasis","year":2016,"lang":"en","type":"review","venue":"Nature Reviews Disease Primers","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":897,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"National Center for Research Resources; National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Psoriasis; Dermatology; Medicine","authors":[{"name":"Jacqueline Greb","is_ca":false},{"name":"Ari M. Goldminz","is_ca":false},{"name":"James T. Elder","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Dafna D. Gladman","is_ca":true},{"name":"Jashin J. Wu","is_ca":false},{"name":"Nehal N. Mehta","is_ca":false},{"name":"A.Y. Finlay","is_ca":false},{"name":"Alice B. Gottlieb","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03310098136570067,"gpt":0.3281866627955874,"spread":0.2950856814298868,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0004897171,0.001125189,0.003543615,0.0003205209,0.0002033385,0.00002589587,0.0008180584,0.001938059,0.002682565],"category_scores_gemma":[0.0004120217,0.0006411795,0.002873614,0.000435119,0.0001551334,0.0001040515,0.0001607193,0.001001842,0.02010102],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002359836,"about_ca_system_score_gemma":0.0005442978,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000001803407,"about_ca_topic_score_gemma":7.360585e-7,"domain_scores_codex":[0.9956952,0.001379945,0.001037771,0.001085855,0.00009005165,0.00071113],"domain_scores_gemma":[0.9972446,0.0003485636,0.0008139517,0.001336666,0.00006185736,0.0001943462],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00003324424,0.00009920775,0.000003164788,0.007703772,0.001125311,0.00002255613,0.00000517086,1.00622e-9,0.000002088942,0.0002717903,0.03206148,0.9586722],"study_design_scores_gemma":[0.0005145532,0.00002224009,0.000009486189,0.02126803,0.007966112,0.00002400447,9.071858e-7,2.084966e-9,0.000005366776,0.00003529084,0.9694422,0.0007117798],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[3.980027e-7,0.9910778,0.000004826863,0.00005387698,0.003837551,0.002285965,0.0007886274,0.00015326,0.001797682],"genre_scores_gemma":[0.000001076168,0.9885454,0.00007363648,0.0001590952,0.0004134766,0.0007824167,0.001659069,0.0001145685,0.008251264],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9579604,"threshold_uncertainty_score":0.9996039,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2063627867","doi":"10.1016/j.jaad.2007.09.010","title":"Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial","year":2007,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":883,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Adalimumab; Psoriasis; Randomized controlled trial; Dermatology; Physical therapy; Internal medicine; Tumor necrosis factor alpha","authors":[{"name":"Alan Menter","is_ca":false},{"name":"Stephen K. Tyring","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Alexa B. Kimball","is_ca":false},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"Bruce Strober","is_ca":false},{"name":"Martin Kaul","is_ca":false},{"name":"Yihua Gu","is_ca":false},{"name":"Martin M. Okun","is_ca":false},{"name":"Kim Papp","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02011710880311059,"gpt":0.3155302584066383,"spread":0.2954131496035277,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001616573,0.0002928867,0.003248722,0.0003312408,0.0001660891,0.000008602555,0.0005966591,0.0002422782,0.00004286249],"category_scores_gemma":[0.0004546373,0.0001638399,0.001397831,0.000260384,0.0005126483,0.00007910142,0.00004978102,0.0003578515,0.000009241886],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004251195,"about_ca_system_score_gemma":0.000158195,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001421948,"about_ca_topic_score_gemma":0.00000209789,"domain_scores_codex":[0.99642,0.00110164,0.001701984,0.0002002707,0.0001042937,0.0004718414],"domain_scores_gemma":[0.994337,0.002429277,0.002849728,0.0001677319,0.0001476121,0.00006862148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9492648,0.0004568581,0.00003244973,0.000005686779,0.003440307,0.000007845746,0.0004181965,0.00001812775,0.02261778,0.0004066637,0.003256751,0.02007457],"study_design_scores_gemma":[0.9226432,0.0009687091,0.00004693119,0.00002922889,0.0008975187,0.001416503,0.0002591687,0.000008753441,0.06576841,0.0006949211,0.007096897,0.0001697545],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9821092,0.004259493,0.002415676,0.007368771,0.001247863,0.002427137,0.00003250134,0.00001471029,0.0001246105],"genre_scores_gemma":[0.9960901,0.0006789562,0.0006356506,0.001964783,0.0002134993,0.00009663872,0.000002900481,0.00002363287,0.0002938466],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.04315063,"threshold_uncertainty_score":0.6681199,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2570141807","doi":"10.1016/j.jaad.2016.11.041","title":"Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial","year":2017,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":860,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Psoriasis; Adalimumab; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Internal medicine; Placebo; Adverse effect; Surgery; Gastroenterology; Dermatology","authors":[{"name":"Andrew Blauvelt","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"C.E.M. Griffiths","is_ca":false},{"name":"B. Randazzo","is_ca":false},{"name":"Yasmine Wasfi","is_ca":false},{"name":"Yaung‐Kaung Shen","is_ca":false},{"name":"Shu Li","is_ca":false},{"name":"Alexa B. Kimball","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03413351889159199,"gpt":0.3233729633831536,"spread":0.2892394444915616,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002486383,0.0003342289,0.001935606,0.00009162314,0.0004498146,0.00002490504,0.0006401668,0.0001329511,0.000004008049],"category_scores_gemma":[0.00007143558,0.0001455686,0.0002029604,0.00008189104,0.001246857,0.0001460475,0.00008830458,0.0002222654,3.402888e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003629472,"about_ca_system_score_gemma":0.0001366968,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002178074,"about_ca_topic_score_gemma":0.00005951143,"domain_scores_codex":[0.9977421,0.0005646701,0.0009986457,0.0002840608,0.0001267497,0.0002837456],"domain_scores_gemma":[0.9936567,0.001766226,0.00391202,0.0004032325,0.0002009968,0.00006080275],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.972634,0.001182362,0.01001472,0.000006378549,0.005709521,0.000004644535,0.002347039,0.0001345847,0.003208132,0.00002864628,0.0001749747,0.004555034],"study_design_scores_gemma":[0.8288165,0.006865943,0.1283557,0.0001331889,0.00293741,0.0002766127,0.001292966,0.00007952117,0.03044214,0.00002382383,0.0005467685,0.0002294444],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940549,0.0006818874,0.0000958278,0.001851106,0.0001778004,0.002245322,0.0008734141,0.000005028417,0.00001468985],"genre_scores_gemma":[0.9993049,0.000251166,0.0002043052,0.00007681593,0.00005541273,0.00003438115,0.00003526992,0.00001824831,0.0000195342],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1438175,"threshold_uncertainty_score":0.5936114,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2149566497","doi":"10.1056/nejmoa0810652","title":"Comparison of Ustekinumab and Etanercept for Moderate-to-Severe Psoriasis","year":2010,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":851,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Ustekinumab; Medicine; Etanercept; Psoriasis; Psoriasis Area and Severity Index; Clinical endpoint; Internal medicine; Secukinumab; Dermatology; Clearance; Gastroenterology; Adalimumab; Randomized controlled trial; Tumor necrosis factor alpha; Psoriatic arthritis; Urology","authors":[{"name":"C.E.M. Griffiths","is_ca":false},{"name":"Bruce Strober","is_ca":false},{"name":"Peter van de Kerkhof","is_ca":false},{"name":"Vincent Ho","is_ca":true},{"name":"Roseanne Fidelus-Gort","is_ca":false},{"name":"Newman Yeilding","is_ca":false},{"name":"Cynthia Guzzo","is_ca":false},{"name":"Yichuan Xia","is_ca":false},{"name":"Shu Li","is_ca":false},{"name":"Lisa T. Dooley","is_ca":false},{"name":"Neil Goldstein","is_ca":false},{"name":"Alan Menter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02972773026265618,"gpt":0.3047776721716203,"spread":0.2750499419089641,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004790861,0.0001371356,0.0006048034,0.0001560832,0.00006616149,0.000003875139,0.0001247248,0.0001518862,0.000309533],"category_scores_gemma":[0.0002603877,0.0000877085,0.0000659407,0.00007437934,0.00008983695,0.00004736132,0.00001626839,0.0002270848,0.000004984807],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000008570104,"about_ca_system_score_gemma":0.00006393724,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004145953,"about_ca_topic_score_gemma":0.00009617121,"domain_scores_codex":[0.9991232,0.00007037031,0.000469205,0.0001134007,0.0000599289,0.0001639067],"domain_scores_gemma":[0.9989512,0.0003880561,0.0002858437,0.0001222575,0.0001691149,0.00008350991],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.005161859,0.0001366899,0.01463846,0.00003596593,0.0004619215,0.000008435629,0.004220865,0.00002756396,0.346853,0.0003719448,0.01536879,0.6127146],"study_design_scores_gemma":[0.2977571,0.01409924,0.05153631,0.0005769746,0.002797225,0.003565917,0.002543539,0.00007378426,0.2148177,0.002817665,0.4087444,0.0006701651],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926807,0.002435202,0.0007697114,0.001552722,0.002026487,0.0001536176,0.00001543308,0.000006232489,0.0003599321],"genre_scores_gemma":[0.9969305,0.0001084258,0.001196652,0.00008657839,0.0008680574,0.000002105646,0.00001367886,0.00001065706,0.0007833775],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6120444,"threshold_uncertainty_score":0.3576649,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2418506270","doi":"10.1056/nejmoa1512711","title":"Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis","year":2016,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":838,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"","keywords":"Ixekizumab; Medicine; Psoriasis; Etanercept; Placebo; Plaque psoriasis; Clinical trial; Interleukin 17; Dermatology; Internal medicine; Tumor necrosis factor alpha; Alternative medicine; Secukinumab; Inflammation; Psoriatic arthritis; Pathology","authors":[{"name":"Kenneth B. Gordon","is_ca":true},{"name":"Andrew Blauvelt","is_ca":true},{"name":"Kim Papp","is_ca":true},{"name":"Richard G. Langley","is_ca":true},{"name":"Thomas A. Luger","is_ca":true},{"name":"Mamitaro Ohtsuki","is_ca":true},{"name":"Kristian Reich","is_ca":true},{"name":"David A. Amato","is_ca":true},{"name":"Susan Ball","is_ca":true},{"name":"Daniel Braun","is_ca":true},{"name":"Gregory S. Cameron","is_ca":true},{"name":"J. Erickson","is_ca":true},{"name":"Robert J. Konrad","is_ca":true},{"name":"Talia M. Muram","is_ca":true},{"name":"Brian J. Nickoloff","is_ca":true},{"name":"Olawale Osuntokun","is_ca":true},{"name":"Roberta J. Secrest","is_ca":true},{"name":"Fangyi Zhao","is_ca":true},{"name":"Lotus Mallbris","is_ca":true},{"name":"Craig L. Leonardi","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04471593433998027,"gpt":0.3116114006828535,"spread":0.2668954663428732,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002291133,0.0001740739,0.001111139,0.0004036436,0.00002917953,0.000002274795,0.0001858798,0.0001562457,0.001183338],"category_scores_gemma":[0.001437208,0.00008566388,0.000132571,0.0001670186,0.00007234942,0.00008632321,0.00001799057,0.0001372163,0.00003158253],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004889465,"about_ca_system_score_gemma":0.0001697662,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009079771,"about_ca_topic_score_gemma":0.0000581081,"domain_scores_codex":[0.9977871,0.0005985123,0.001158882,0.0001390259,0.00009180875,0.0002247206],"domain_scores_gemma":[0.9978675,0.001163032,0.0005850453,0.0001624395,0.0001330007,0.00008894243],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.01496086,0.000279166,0.000733586,0.000009463402,0.0003763463,0.00008240342,0.001069291,0.000008450555,0.2042549,0.0001229277,0.009539811,0.7685629],"study_design_scores_gemma":[0.6594738,0.009185801,0.002749345,0.001539438,0.0007290127,0.001267132,0.0003115511,0.000001199107,0.2172817,0.002183668,0.1049844,0.0002928677],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9864787,0.004582148,0.000890937,0.00564512,0.001758746,0.0001758119,0.00004430492,0.000007273546,0.000416975],"genre_scores_gemma":[0.9963778,0.001016872,0.0001601333,0.0001097752,0.0009583548,0.000002752702,0.000008538206,0.0000116471,0.001354145],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.76827,"threshold_uncertainty_score":0.9997297,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2171889601","doi":"10.1016/s0140-6736(15)60125-8","title":"Comparison of ixekizumab with etanercept or placebo in moderate-to-severe psoriasis (UNCOVER-2 and UNCOVER-3): results from two phase 3 randomised trials","year":2015,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":831,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"National Institute for Health and Care Research; Eli Lilly and Company","keywords":"Ixekizumab; Medicine; Etanercept; Placebo; Psoriasis; Psoriasis Area and Severity Index; Internal medicine; Clinical trial; Blinding; Interleukin 17; Physical therapy; Dermatology; Psoriatic arthritis; Cytokine; Tumor necrosis factor alpha; Secukinumab; Pathology; Alternative medicine","authors":[{"name":"C.E.M. Griffiths","is_ca":false},{"name":"Kristian Reich","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Peter van de Kerkhof","is_ca":false},{"name":"C. Paul","is_ca":false},{"name":"Alan Menter","is_ca":false},{"name":"Gregory S. Cameron","is_ca":false},{"name":"J. Erickson","is_ca":false},{"name":"Lu Zhang","is_ca":false},{"name":"Roberta J. Secrest","is_ca":false},{"name":"Susan Ball","is_ca":false},{"name":"Daniel Braun","is_ca":false},{"name":"Olawale Osuntokun","is_ca":false},{"name":"Michael Heffernan","is_ca":false},{"name":"Brian J. Nickoloff","is_ca":false},{"name":"Kim Papp","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1149020683539135,"gpt":0.3566539598176311,"spread":0.2417518914637176,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001629879,0.0002622129,0.00163654,0.00008315462,0.00008123971,0.0000257859,0.0002758461,0.000158949,0.0001136671],"category_scores_gemma":[0.0007386482,0.0001400629,0.00007301883,0.0002076873,0.0001078102,0.00008269056,0.00006271729,0.0001739101,0.00006903315],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005255992,"about_ca_system_score_gemma":0.0001402379,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009592567,"about_ca_topic_score_gemma":0.001344536,"domain_scores_codex":[0.9973425,0.001241038,0.0006495154,0.0003578842,0.00008359047,0.0003254505],"domain_scores_gemma":[0.9971092,0.001905157,0.0003373112,0.0005324181,0.00006604163,0.00004982023],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9234532,0.000383154,0.002743824,0.00001283159,0.0008480287,0.00001964682,0.008392278,0.001531025,0.008095528,0.00003817087,0.01575015,0.03873218],"study_design_scores_gemma":[0.9117233,0.001964308,0.002257967,0.0001930781,0.0008062695,0.0000313194,0.002361277,0.0002313191,0.06754448,0.0005313086,0.01184326,0.0005121517],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9940568,0.001406746,0.0001133621,0.000576179,0.0003789836,0.000948846,0.001319005,0.00003812868,0.001161971],"genre_scores_gemma":[0.9977745,0.0001035105,0.0004146452,0.0001299679,0.0002004728,0.00006380998,0.0003353686,0.00001841542,0.0009592585],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05944895,"threshold_uncertainty_score":0.5711601,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2326643498","doi":"10.1056/nejmoa1503824","title":"Phase 3 Studies Comparing Brodalumab with Ustekinumab in Psoriasis","year":2015,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":806,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"XLV Diagnostics (Canada); Dalhousie University; Probity Medical Research","funders":"","keywords":"Medicine; Ustekinumab; Psoriasis; Dermatology; Ixekizumab; Internal medicine; Secukinumab; Psoriatic arthritis; Disease; Infliximab","authors":[{"name":"Mark Lebwohl","is_ca":true},{"name":"Bruce Strober","is_ca":true},{"name":"Alan Menter","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Jolanta Węgłowska","is_ca":false},{"name":"L. Puig","is_ca":false},{"name":"Kim Papp","is_ca":false},{"name":"Lynda Spelman","is_ca":true},{"name":"Darryl Toth","is_ca":true},{"name":"Francisco A. Kerdel","is_ca":false},{"name":"April W. Armstrong","is_ca":false},{"name":"Georg Stingl","is_ca":false},{"name":"Alexa B. Kimball","is_ca":false},{"name":"H. Bachelez","is_ca":false},{"name":"Jashin J. Wu","is_ca":false},{"name":"Jeffrey Crowley","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"Tomasz Blicharski","is_ca":false},{"name":"C. Paul","is_ca":false},{"name":"J.‐P. Lacour","is_ca":false},{"name":"Stephen K. Tyring","is_ca":false},{"name":"Leon Kircik","is_ca":false},{"name":"Sergio Chimenti","is_ca":false},{"name":"Kristina Callis Duffin","is_ca":false},{"name":"Jerry Bagel","is_ca":false},{"name":"John Koo","is_ca":false},{"name":"Gary Aras","is_ca":false},{"name":"Joanne Li","is_ca":false},{"name":"Wenjie Song","is_ca":false},{"name":"Cassandra E. Milmont","is_ca":false},{"name":"Yifei Shi","is_ca":false},{"name":"Ngozi Erondu","is_ca":false},{"name":"Paul Klekotka","is_ca":false},{"name":"Brian L. Kotzin","is_ca":false},{"name":"Ajay Nirula","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07908791848008138,"gpt":0.3240991282479725,"spread":0.2450112097678911,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008658749,0.000167633,0.0006830383,0.000251312,0.000040411,0.000004001442,0.0001409649,0.0000729762,0.00006043406],"category_scores_gemma":[0.0002672133,0.00009455631,0.0000400478,0.00018814,0.0001332998,0.00009817274,0.00002047653,0.0002392634,0.00001693253],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008716136,"about_ca_system_score_gemma":0.0001536068,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001279466,"about_ca_topic_score_gemma":0.0002784466,"domain_scores_codex":[0.998889,0.0002098458,0.0004616051,0.0001219645,0.0001021832,0.000215364],"domain_scores_gemma":[0.9991025,0.0002116407,0.0002832692,0.0001269129,0.0001921188,0.00008357081],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.0208799,0.001102214,0.06959794,0.00004671629,0.002693916,0.001284757,0.02677189,0.0001688512,0.009233616,0.000226629,0.03412835,0.8338652],"study_design_scores_gemma":[0.845829,0.01573716,0.007121796,0.001210466,0.001201761,0.005541698,0.009994206,0.000008478719,0.006849364,0.0007928218,0.1053467,0.0003665164],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9678658,0.02834935,0.00008125661,0.001276027,0.001500413,0.00008318928,0.00000147175,0.00001081482,0.0008317068],"genre_scores_gemma":[0.9975757,0.0005871814,0.0001851023,0.00007276778,0.0009059533,0.000001655187,0.000008376014,0.00001049165,0.0006527458],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8334987,"threshold_uncertainty_score":0.3855895,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2071343804","doi":"10.1056/nejmoa062382","title":"A Human Interleukin-12/23 Monoclonal Antibody for the Treatment of Psoriasis","year":2007,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":785,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Psoriasis; Monoclonal antibody; Monoclonal; Immunology; Interleukin 23; Ixekizumab; Interleukin; Interleukin 2; Dermatology; Antibody; Cytokine; Secukinumab; Psoriatic arthritis","authors":[{"name":"Gerald G. Krueger","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Newman Yeilding","is_ca":false},{"name":"Cynthia Guzzo","is_ca":false},{"name":"Yuhua Wang","is_ca":false},{"name":"Lisa T. Dooley","is_ca":false},{"name":"Mark Lebwohl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03264787616484358,"gpt":0.3145769993690694,"spread":0.2819291232042258,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008339796,0.0001710247,0.0004976645,0.0001698914,0.0001185401,0.000003083398,0.0001806818,0.0001068127,0.0002236864],"category_scores_gemma":[0.00007287552,0.00008311569,0.0002041947,0.00007966479,0.0001519174,0.0000355823,0.000008041048,0.00009629933,0.000005264161],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005186744,"about_ca_system_score_gemma":0.00005988584,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001377582,"about_ca_topic_score_gemma":0.0001548963,"domain_scores_codex":[0.9989164,0.00007646074,0.000596369,0.0001082645,0.00007296978,0.0002295199],"domain_scores_gemma":[0.9984598,0.0007778527,0.0004245068,0.0001641843,0.000121632,0.00005198577],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003766286,0.0004656317,0.009697237,0.00001490399,0.002005701,0.00005452508,0.004324063,0.000004900901,0.2183588,0.0004142998,0.005181349,0.7557123],"study_design_scores_gemma":[0.1662412,0.02291218,0.07319113,0.0002754228,0.002767139,0.001310995,0.001460673,0.000002492279,0.1241096,0.0008838021,0.606611,0.0002343898],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9776493,0.01596048,0.001972157,0.00131414,0.002393254,0.0002521708,0.00001577822,0.000008290506,0.0004344117],"genre_scores_gemma":[0.993831,0.001224472,0.0002234891,0.0000644788,0.002276686,0.000002808921,0.0000378124,0.00001290096,0.002326355],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7554778,"threshold_uncertainty_score":0.3389359,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2093785176","doi":"10.1182/blood-2009-04-216085","title":"Evidence for a cross-talk between human neutrophils and Th17 cells","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":761,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"Canadian Institutes of Health Research; Università degli Studi di Verona; Fondazione Cassa di Risparmio di Verona Vicenza Belluno e Ancona; Associazione Italiana per la Ricerca sul Cancro","keywords":"CCL20; C-C chemokine receptor type 6; Chemokine; Interleukin 17; Immunology; Chemotaxis; Tumor necrosis factor alpha; Biology; CCR2; CXCL16; Chemokine receptor; Cell biology; Cytokine; Inflammation; Receptor","authors":[{"name":"Martin Pelletier","is_ca":false},{"name":"Laura Maggi","is_ca":false},{"name":"Alessandra Micheletti","is_ca":false},{"name":"Elena Lazzeri","is_ca":false},{"name":"Nicola Tamassia","is_ca":false},{"name":"Claudio Costantini","is_ca":false},{"name":"Lorenzo Cosmi","is_ca":false},{"name":"Claudio Lunardi","is_ca":false},{"name":"Francesco Annunziato","is_ca":false},{"name":"Sergio Romagnani","is_ca":false},{"name":"Marco A. Cassatella","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05511394460269681,"gpt":0.308155979884125,"spread":0.2530420352814282,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001152229,0.0001415409,0.0002128141,0.00004385844,0.0002536904,0.00002772497,0.0001237001,0.0001686691,0.0000429854],"category_scores_gemma":[0.00002161896,0.0001215554,0.00008291908,0.00004718391,0.00007424139,0.0001032578,0.00002146363,0.00006144271,0.00004416394],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000006199807,"about_ca_system_score_gemma":0.00001397356,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001387248,"about_ca_topic_score_gemma":0.000003590977,"domain_scores_codex":[0.9992515,0.00004641473,0.0001599561,0.0002640403,0.00001682839,0.0002613045],"domain_scores_gemma":[0.9995196,0.0001687815,0.00006233095,0.0001961801,0.00002945763,0.00002366588],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00007908521,0.0002355367,0.03039405,0.00001737143,0.0002228274,0.000008874374,0.0001769952,2.149378e-7,0.9541185,0.0002939702,0.0002704225,0.01418215],"study_design_scores_gemma":[0.004061205,0.000855617,0.347176,0.00005074032,0.000471892,0.00002257118,0.00001092844,5.83511e-8,0.6434155,0.0007076403,0.003036717,0.0001911703],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914837,0.007559636,0.00001497406,0.0001121189,0.0001229038,0.0002822886,0.00006737099,0.0000544542,0.0003024878],"genre_scores_gemma":[0.9981551,0.0001776003,0.0001362918,0.00007062485,0.0001262934,0.00002395359,0.00006491515,0.000008710539,0.001236545],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3167819,"threshold_uncertainty_score":0.4956885,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2163232748","doi":"10.1111/j.1365-2133.2007.08315.x","title":"Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)","year":2007,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":722,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"Abbott Laboratories","keywords":"Champion; SAINT; Medicine; Nice; Humanities; Library science; Art; Political science; Art history; Law","authors":[{"name":"J.‐H. Saurat","is_ca":true},{"name":"G Stingl","is_ca":true},{"name":"Louis Dubertret","is_ca":true},{"name":"Kim Papp","is_ca":true},{"name":"Richard G. Langley","is_ca":true},{"name":"J.‐P. Ortonne","is_ca":true},{"name":"Kristina Unnebrink","is_ca":true},{"name":"Martin Kaul","is_ca":true},{"name":"A. Camez","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01153006131279974,"gpt":0.2450423416198201,"spread":0.2335122803070204,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001638291,0.0002390586,0.002530762,0.0001780854,0.0001581788,0.00001771357,0.0002336749,0.0001992148,0.00003682058],"category_scores_gemma":[0.0006437183,0.0001563065,0.0001768788,0.0001724863,0.0003450901,0.0001029836,0.00005107426,0.0003617082,0.000004411183],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002965481,"about_ca_system_score_gemma":0.00007121718,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005064841,"about_ca_topic_score_gemma":0.001248004,"domain_scores_codex":[0.9943991,0.003222939,0.001713344,0.0002454362,0.0001120034,0.0003072101],"domain_scores_gemma":[0.9908189,0.007302253,0.001385539,0.0001768882,0.0002760999,0.00004036876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9453474,0.001518855,0.03739752,0.000003536433,0.003468962,0.0003552766,0.004623429,0.00001270655,0.00005827999,0.0000177992,0.0002451416,0.006951044],"study_design_scores_gemma":[0.6743008,0.00059025,0.3213987,0.0001238664,0.0007423407,0.0008080226,0.001232079,0.000001418164,0.0005506586,0.00002267846,0.0001102875,0.0001188297],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9933129,0.004087202,0.00009668258,0.0001936435,0.0004066431,0.001659204,0.00008829239,0.000008132154,0.000147332],"genre_scores_gemma":[0.9992248,0.0004174403,0.0001723989,0.00005263215,0.00002358273,0.00001611763,0.00005470385,0.00001213681,0.00002616572],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2840012,"threshold_uncertainty_score":0.6373993,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2146843653","doi":"10.1111/j.1365-2133.2005.06688.x","title":"A global phase III randomized controlled trial of etanercept in psoriasis: safety, efficacy, and effect of dose reduction","year":2005,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":692,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Probity Medical Research","funders":"","keywords":"SAINT; Medicine; Library science; Family medicine; Art history; Art","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Stephen K. Tyring","is_ca":true},{"name":"M. Lahfa","is_ca":true},{"name":"Jörg C. Prinz","is_ca":true},{"name":"C.E.M. Griffiths","is_ca":true},{"name":"Arline Nakanishi","is_ca":true},{"name":"Ralph Zitnik","is_ca":true},{"name":"P.C.M. van de Kerkhof","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.006313327572443979,"gpt":0.2618050005215208,"spread":0.2554916729490769,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001197451,0.0001984752,0.003117771,0.0002198385,0.00005391031,0.000007834468,0.000148117,0.0003538904,0.0001039264],"category_scores_gemma":[0.0005826309,0.0001685198,0.0004918266,0.0001584298,0.0003820897,0.000114516,0.00003031377,0.0001898321,0.000003495604],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000419588,"about_ca_system_score_gemma":0.0001206977,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008383337,"about_ca_topic_score_gemma":0.00005223435,"domain_scores_codex":[0.9951937,0.002479295,0.001839481,0.0001702144,0.00007016003,0.0002471165],"domain_scores_gemma":[0.997555,0.000950559,0.001228795,0.0001113087,0.0001167567,0.00003757716],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.88214,0.0009221508,0.0001338852,0.00002401169,0.001284893,0.0001985387,0.0001572091,0.000009390867,0.005064143,0.00006511379,0.0002260873,0.1097745],"study_design_scores_gemma":[0.955614,0.001141748,0.0004198181,0.0001743098,0.001212289,0.03271232,0.00005139879,0.000005045636,0.008331115,0.00004326284,0.0001846897,0.0001099724],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9735205,0.02347063,0.00003826114,0.0002560728,0.001055449,0.001366772,0.00002628107,0.000008244384,0.0002578361],"genre_scores_gemma":[0.9957143,0.003996266,0.00009002224,0.00000955438,0.0000924994,0.00003379478,0.00001637182,0.00000857884,0.00003863024],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1096646,"threshold_uncertainty_score":0.6872039,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1919283206","doi":"10.1016/j.jaad.2015.03.049","title":"Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)","year":2015,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":669,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University; Probity Medical Research","funders":"Ortho-McNeil Pharmaceutical; Janssen Pharmaceuticals; Johnson and Johnson; Janssen Biotech; 3M; Merck Sharp and Dohme; Biogen Idec; Genentech; LEO Pharma; Abbott Laboratories; National Institute for Health and Care Research; Sandoz; Novartis; Celgene; Merck; GlaxoSmithKline; Astellas Pharma US; Galderma; Eli Lilly and Company; Pfizer; Amgen; AbbVie; Society of Daughters of the United States Army; Allergan; Merz Therapeutics","keywords":"Apremilast; Medicine; Psoriasis; Plaque psoriasis; Randomized controlled trial; Dermatology; Phosphodiesterase inhibitor; Phosphodiesterase; Internal medicine; Pharmacology; Clinical trial; Psoriatic arthritis; Enzyme","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Kristian Reich","is_ca":false},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Leon Kircik","is_ca":false},{"name":"Sergio Chimenti","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"ChiaChi Hu","is_ca":false},{"name":"Randall M. Stevens","is_ca":false},{"name":"Robert M. Day","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Neil J. Korman","is_ca":false},{"name":"C.E.M. Griffiths","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01953649670246773,"gpt":0.3023714075668437,"spread":0.282834910864376,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002691841,0.0003883426,0.003836533,0.0004079342,0.00007831598,0.0000093772,0.0005254612,0.0002691033,0.000002998946],"category_scores_gemma":[0.003024415,0.0002076934,0.0003410974,0.0004948365,0.0007896697,0.0001873117,0.0001383505,0.0005931265,6.342948e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00008333378,"about_ca_system_score_gemma":0.0003851081,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001390558,"about_ca_topic_score_gemma":0.00003208331,"domain_scores_codex":[0.9906915,0.00559742,0.002724572,0.0003188336,0.0002711294,0.0003965161],"domain_scores_gemma":[0.9910508,0.004172739,0.004177646,0.0002775943,0.0002276471,0.00009352442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9837151,0.001838279,0.001443861,0.00002981293,0.001095188,0.000007332624,0.003419059,0.0003296461,0.002561916,0.00001440716,0.0001700368,0.005375386],"study_design_scores_gemma":[0.9755228,0.009210651,0.001371943,0.0003532903,0.00103743,0.0001187589,0.0004705492,0.00005912252,0.01157455,0.00006340456,0.0000254659,0.0001919993],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9931135,0.0008277688,0.00001756255,0.0007702807,0.0007877958,0.004407356,0.00004897023,0.000005924544,0.00002083804],"genre_scores_gemma":[0.9992127,0.0001445401,0.0002650299,0.0001462841,0.0000717505,0.0001124174,0.000007653412,0.0000219673,0.00001763999],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009012634,"threshold_uncertainty_score":0.8469492,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2887412253","doi":"10.1016/s0140-6736(18)31713-6","title":"Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials","year":2018,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":662,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; Centre de Recherche Dermatologique du Québec Métropolitain","funders":"Dermira; Genentech; Celgene; AbbVie; GlaxoSmithKline Australia; Bristol-Myers Squibb; Amgen; Boehringer Ingelheim","keywords":"Medicine; Ustekinumab; Placebo; Psoriasis Area and Severity Index; Internal medicine; Psoriasis; Clinical trial; Randomization; Randomized controlled trial; Gastroenterology; Dermatology; Tumor necrosis factor alpha; Pathology","authors":[{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Bruce Strober","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Matthias Augustin","is_ca":false},{"name":"Andrew Blauvelt","is_ca":false},{"name":"Yves Poulin","is_ca":true},{"name":"Kim Papp","is_ca":true},{"name":"Howard Sofen","is_ca":false},{"name":"L. Puig","is_ca":false},{"name":"Peter Foley","is_ca":false},{"name":"Mamitaro Ohtsuki","is_ca":false},{"name":"Mary Flack","is_ca":false},{"name":"Ziqian Geng","is_ca":false},{"name":"Yihua Gu","is_ca":false},{"name":"Joaquin Valdes","is_ca":false},{"name":"Elizabeth H. Thompson","is_ca":false},{"name":"H. Bachelez","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.05257706308536371,"gpt":0.3200678952590045,"spread":0.2674908321736408,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003334084,0.0004531125,0.003195923,0.0001929256,0.0002954866,0.00006360687,0.0002809027,0.0003095127,0.0001155686],"category_scores_gemma":[0.001103346,0.0002789656,0.0001685815,0.0001752761,0.0003360117,0.0001121813,0.0001226496,0.0002529209,0.00003416836],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003141238,"about_ca_system_score_gemma":0.00006422427,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007054163,"about_ca_topic_score_gemma":0.0004513386,"domain_scores_codex":[0.9956046,0.001854674,0.001306474,0.0006527904,0.00008150827,0.0004999324],"domain_scores_gemma":[0.9928499,0.005814336,0.0005675862,0.0006105569,0.00008752284,0.00007009877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9587726,0.0002152577,0.0002021889,0.00001169042,0.001624556,0.000009011631,0.002812548,0.00004237998,0.01805523,0.00007755677,0.0005875492,0.01758941],"study_design_scores_gemma":[0.9835325,0.0005590736,0.001194691,0.0001138597,0.0009800562,0.00002766055,0.0001710735,0.0002658926,0.01183307,0.0001937558,0.0008211086,0.0003072113],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9873417,0.004580262,0.00005277123,0.0009428747,0.0004523095,0.004845208,0.0009188337,0.00004794331,0.0008180965],"genre_scores_gemma":[0.9967341,0.001355012,0.0002378292,0.000128803,0.0005078047,0.0002887519,0.0001937296,0.00002839494,0.0005255952],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02475993,"threshold_uncertainty_score":0.9999663,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2050172669","doi":"10.1016/j.jaad.2004.04.012","title":"Evaluating psoriasis with Psoriasis Area and Severity Index, Psoriasis Global Assessment, and Lattice System Physician's Global Assessment","year":2004,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":608,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Psoriasis; Medicine; Psoriasis Area and Severity Index; Inter-rater reliability; Cronbach's alpha; Concordance; Severity of illness; Clinical trial; Physical therapy; Dermatology; Psychometrics; Internal medicine; Rating scale; Statistics; Clinical psychology","authors":[{"name":"Richard G. Langley","is_ca":true},{"name":"Charles N. Ellis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0246171263484653,"gpt":0.3342530989070339,"spread":0.3096359725585686,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005239523,0.0004481968,0.001426944,0.0001182202,0.0003428278,0.00003278525,0.0005332733,0.0002922063,0.000007448517],"category_scores_gemma":[0.00005957517,0.0003031522,0.0002505495,0.0006200821,0.001021588,0.0003109878,0.0002405115,0.0005874772,0.000003122513],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005067247,"about_ca_system_score_gemma":0.0004657067,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001827983,"about_ca_topic_score_gemma":0.00001956488,"domain_scores_codex":[0.9968042,0.001026947,0.0009348847,0.0004192507,0.0002750539,0.0005396652],"domain_scores_gemma":[0.996625,0.0003145222,0.002522691,0.0002626178,0.0001688761,0.0001062926],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00234236,0.0006519455,0.8819236,0.0002584824,0.005845776,0.0001009469,0.0003852834,0.000259282,0.005971565,0.009107665,0.0003952978,0.09275778],"study_design_scores_gemma":[0.009857432,0.0009286909,0.9637477,0.0003812033,0.002686813,0.01390043,0.002557807,0.00005841126,0.003066782,0.001843762,0.0005007146,0.0004702016],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9924634,0.001744778,0.0006983503,0.003566922,0.0005391098,0.0003127781,0.0001257729,0.00003256501,0.0005163296],"genre_scores_gemma":[0.9938533,0.0003727632,0.005126219,0.0005030166,0.00009590898,0.00001467318,0.000004250434,0.000019991,0.000009868553],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09228759,"threshold_uncertainty_score":0.9999421,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2021674244","doi":"10.1038/ni1439","title":"The adaptor Act1 is required for interleukin 17–dependent signaling associated with autoimmune and inflammatory disease","year":2007,"lang":"en","type":"article","venue":"Nature Immunology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":604,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Institute of Neurological Disorders and Stroke; National Institute of Allergy and Infectious Diseases; National Institutes of Health","keywords":"Ubiquitin ligase; Experimental autoimmune encephalomyelitis; Inflammation; Signal transducing adaptor protein; Immunology; Signal transduction; Biology; Cell biology; Immune system; Ubiquitin; Gene","authors":[{"name":"Youcun Qian","is_ca":false},{"name":"Caini Liu","is_ca":false},{"name":"Justin Hartupee","is_ca":false},{"name":"Cengiz Z. Altuntas","is_ca":false},{"name":"Muhammet F. Gülen","is_ca":false},{"name":"Dan Jane‐wit","is_ca":false},{"name":"Jianhua Xiao","is_ca":false},{"name":"Yi Lu","is_ca":false},{"name":"Natalia V. Giltiay","is_ca":false},{"name":"Jinbo Liu","is_ca":false},{"name":"Tomasz Kordula","is_ca":false},{"name":"Bruce A. Vallance","is_ca":true},{"name":"Shadi Swaidani","is_ca":false},{"name":"Mark Aronica","is_ca":false},{"name":"Vincent K. Tuohy","is_ca":false},{"name":"Thomas A. Hamilton","is_ca":false},{"name":"Xiaoxia Li","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.008614561718123904,"gpt":0.2342258043554022,"spread":0.2256112426372783,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007390684,0.0003239413,0.0003627365,0.0001278882,0.0006544722,0.00003267816,0.0003337162,0.0008853217,0.00004657764],"category_scores_gemma":[0.0003207439,0.0002134418,0.0001263993,0.0001320792,0.0004061709,0.0001010473,0.0001054901,0.0006293932,0.00002086477],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001301483,"about_ca_system_score_gemma":0.0001225736,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001056278,"about_ca_topic_score_gemma":0.0001045545,"domain_scores_codex":[0.998263,0.0001895151,0.0003873177,0.0004273883,0.00005996335,0.0006728437],"domain_scores_gemma":[0.9979539,0.001148479,0.0002763688,0.0004157999,0.0001665986,0.00003884064],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.02279461,0.0005004473,0.01082132,0.00004280476,0.008205405,0.0001863225,0.001805195,0.00000289607,0.8762563,0.005850878,0.004589186,0.0689446],"study_design_scores_gemma":[0.02111585,0.002127151,0.4354392,0.000395945,0.001638484,0.00020407,0.001954035,0.00001367157,0.3670805,0.001649535,0.1668735,0.001507983],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9430612,0.0538137,0.0001168193,0.0006533881,0.001171692,0.0006625672,0.0001441642,0.0001419655,0.0002344797],"genre_scores_gemma":[0.9947861,0.0003009627,0.00005813158,0.0003500525,0.00006026682,0.00009406991,0.0002418478,0.00003833414,0.004070271],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5091758,"threshold_uncertainty_score":0.8703902,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2152976783","doi":"10.1056/nejmoa030002","title":"A Novel Targeted T-Cell Modulator, Efalizumab, for Plaque Psoriasis","year":2003,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":580,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Placebo; Psoriasis Area and Severity Index; Internal medicine; Gastroenterology; Immunology; Pharmacology; Plaque psoriasis; Pathology","authors":[{"name":"Mark Lebwohl","is_ca":false},{"name":"Stephen K. Tyring","is_ca":false},{"name":"Tiffani K. Hamilton","is_ca":false},{"name":"Darryl Toth","is_ca":true},{"name":"Scott D. Glazer","is_ca":false},{"name":"Naji Tawfik","is_ca":false},{"name":"Patricia A. Walicke","is_ca":false},{"name":"Wolfgang Dummer","is_ca":false},{"name":"Xiaolin Wang","is_ca":false},{"name":"Marvin R. Garovoy","is_ca":false},{"name":"David M. Pariser","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0206780530635987,"gpt":0.2453775974936594,"spread":0.2246995444300607,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000719072,0.0002115962,0.0005443881,0.0001913515,0.0001036335,0.000005144268,0.0001613478,0.0001905281,0.0005419286],"category_scores_gemma":[0.0003719549,0.0001391746,0.0001532976,0.0001320212,0.00007315959,0.00006858231,0.000008023248,0.0001970254,0.00001998506],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004304399,"about_ca_system_score_gemma":0.0001740196,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004417985,"about_ca_topic_score_gemma":0.00001737467,"domain_scores_codex":[0.998798,0.000139863,0.0005255587,0.0001619481,0.00007852774,0.0002961043],"domain_scores_gemma":[0.9988121,0.0003964507,0.0003575161,0.000166632,0.0001698694,0.000097432],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003671833,0.0005233074,0.002054543,0.00005479529,0.001175932,0.00005986412,0.002024287,0.00006133287,0.7819216,0.002334785,0.06549786,0.1406199],"study_design_scores_gemma":[0.1969698,0.002804579,0.001258452,0.0001403002,0.0008614252,0.001814672,0.0002844215,0.000004755502,0.1475035,0.001354589,0.6467391,0.0002643919],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9245596,0.03450935,0.02293235,0.002874668,0.0104709,0.0005698958,0.0000657514,0.00004680349,0.003970714],"genre_scores_gemma":[0.9919273,0.0004681988,0.002480325,0.0002279983,0.001228394,0.00000584813,0.000038302,0.00002556963,0.003598036],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6344181,"threshold_uncertainty_score":0.5933738,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2623888527","doi":"10.1016/s0140-6736(17)31279-5","title":"Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials","year":2017,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":556,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Etanercept; Placebo; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Clinical trial; Dermatology; Physical therapy; Gastroenterology; Tumor necrosis factor alpha; Alternative medicine; Pathology","authors":[{"name":"Kristian Reich","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Andrew Blauvelt","is_ca":false},{"name":"Stephen K. Tyring","is_ca":false},{"name":"Rodney Sinclair","is_ca":false},{"name":"Diamant Thaçi","is_ca":false},{"name":"Kristine Nograles","is_ca":false},{"name":"Anish Mehta","is_ca":false},{"name":"N. Cichanowitz","is_ca":false},{"name":"Qing Li","is_ca":false},{"name":"Kenneth Liu","is_ca":false},{"name":"Carmen La Rosa","is_ca":false},{"name":"Stuart Green","is_ca":false},{"name":"Alexa B. Kimball","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1043647610923764,"gpt":0.3656328327658314,"spread":0.261268071673455,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003213419,0.000398553,0.002019948,0.00004089148,0.001112681,0.0001486445,0.0007745075,0.0003031406,0.0003320492],"category_scores_gemma":[0.004844829,0.0002225205,0.0003268719,0.00003909953,0.0003189147,0.0001342871,0.0001145568,0.0002260958,0.0001565425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007911711,"about_ca_system_score_gemma":0.0001616511,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004487243,"about_ca_topic_score_gemma":0.0007290863,"domain_scores_codex":[0.9967352,0.001275393,0.0007484973,0.0005790719,0.00006957939,0.0005923251],"domain_scores_gemma":[0.9870803,0.01049535,0.0008513285,0.001456023,0.00006868075,0.00004828741],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9048159,0.00009043929,0.00001466741,0.00001232847,0.002496087,0.00001178057,0.0006730525,0.00003046333,0.02504149,0.0001198597,0.02648234,0.04021163],"study_design_scores_gemma":[0.8929906,0.0007357511,0.0001943716,0.00005990682,0.001527003,0.000008758801,0.0001253731,0.0001082772,0.024029,0.0001796223,0.07973345,0.0003078622],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9633646,0.01233816,0.0001454801,0.005302125,0.004100666,0.005014522,0.00707484,0.0001540282,0.002505563],"genre_scores_gemma":[0.9858506,0.003441098,0.0005530073,0.00009836382,0.001743963,0.000460572,0.0006888873,0.00004634455,0.007117158],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05325111,"threshold_uncertainty_score":0.9074121,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2111980183","doi":"10.4049/jimmunol.170.10.4886","title":"Cutting Edge: Role of IL-27/WSX-1 Signaling for Induction of T-Bet Through Activation of STAT1 During Initial Th1 Commitment","year":2003,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":530,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Cell biology; Signal transduction; STAT1; Chemistry; Biology","authors":[{"name":"Atsunobu Takeda","is_ca":false},{"name":"Shinjiro Hamano","is_ca":false},{"name":"Atsushi Yamanaka","is_ca":false},{"name":"Toshikatsu Hanada","is_ca":false},{"name":"Tatsuro Ishibashi","is_ca":false},{"name":"Tak W. Mak","is_ca":true},{"name":"Akihiko Yoshimura","is_ca":false},{"name":"Hiroki Yoshida","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02701221044402116,"gpt":0.266923352573986,"spread":0.2399111421299649,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007445152,0.0001441026,0.0004825435,0.0001504175,0.0001278084,0.000002068845,0.000201175,0.0002012352,0.00006021555],"category_scores_gemma":[0.0001878492,0.0001041818,0.0001683474,0.0001330841,0.0002136415,0.0001507227,0.00003425429,0.0002191944,0.000001769453],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006827003,"about_ca_system_score_gemma":0.0001228138,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0000416639,"about_ca_topic_score_gemma":0.000001917849,"domain_scores_codex":[0.9982622,0.0005815119,0.000790362,0.00008742891,0.00005239377,0.000226054],"domain_scores_gemma":[0.9975523,0.0005152918,0.001439526,0.0001873315,0.0002978836,0.000007663307],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.00193961,0.0002559797,0.0007918935,0.00003604554,0.001250887,4.881446e-7,0.00356248,0.0001311973,0.9835019,0.0008383048,0.00001759813,0.007673595],"study_design_scores_gemma":[0.003052105,0.0009230508,0.003646543,0.000095137,0.0003134916,0.0001337436,0.004277295,6.036345e-7,0.9854199,0.001437174,0.0006243965,0.00007661567],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9938133,0.004332877,0.0005894789,0.0000637503,0.0007321031,0.0002412542,0.0000306067,0.000005089915,0.0001915773],"genre_scores_gemma":[0.9989606,0.0003651095,0.0005300647,0.000008515852,0.00004850467,0.000006904982,0.00001341332,0.00001357791,0.00005332228],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.007596979,"threshold_uncertainty_score":0.4248411,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168384861","doi":"10.1016/j.jaut.2009.12.001","title":"Geoepidemiology and environmental factors of psoriasis and psoriatic arthritis","year":2009,"lang":"en","type":"review","venue":"Journal of Autoimmunity","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":518,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Psoriasis; Psoriatic arthritis; Medicine; Epidemiology; Incidence (geometry); Obesity; Demography; Dermatology; Internal medicine","authors":[{"name":"Vinod Chandran","is_ca":true},{"name":"S. P. Raychaudhuri","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03600848533808458,"gpt":0.2795983337620942,"spread":0.2435898484240096,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009030469,0.0004617706,0.00317223,0.0003528004,0.0001563509,0.000009836383,0.0002681656,0.0007638935,0.0001410016],"category_scores_gemma":[0.0002428266,0.0003323345,0.0005508819,0.00009733374,0.0003721732,0.0001109496,0.0001099335,0.0007522192,0.000007828629],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007437025,"about_ca_system_score_gemma":0.0001230941,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003268624,"about_ca_topic_score_gemma":0.00000302614,"domain_scores_codex":[0.9966139,0.001399301,0.001433532,0.0002070072,0.00005601473,0.0002902055],"domain_scores_gemma":[0.9965513,0.001093576,0.001971527,0.0003010886,0.00003011272,0.00005244401],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004013283,0.0001820398,0.0003203661,0.0005522562,0.001312516,0.00001480235,0.0002354898,1.041956e-7,0.0000635564,0.00003060883,0.0001283182,0.9971198],"study_design_scores_gemma":[0.002710422,0.001811638,0.02293259,0.005631967,0.005228143,0.002876385,0.0003622404,2.788511e-7,0.0001227485,0.00036262,0.957386,0.0005750025],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.07877535,0.9201176,0.000003502794,0.00001246613,0.0006734067,0.0001963814,0.0001767708,0.000007934058,0.00003662886],"genre_scores_gemma":[0.01393925,0.9855722,0.000102665,0.00001074362,0.00005495621,0.000003131118,0.0001788348,0.0000227473,0.0001154913],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9965448,"threshold_uncertainty_score":0.9999129,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1975463338","doi":"10.1016/j.jaad.2006.07.017","title":"A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":517,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Infliximab; Maintenance therapy; Psoriasis; Maintenance dose; Placebo; Randomized controlled trial; Internal medicine; Surgery; Gastroenterology; Chemotherapy; Dermatology; Tumor necrosis factor alpha","authors":[{"name":"Alan Menter","is_ca":false},{"name":"Steven R. Feldman","is_ca":false},{"name":"Gerald D. Weinstein","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Robert J. Evans","is_ca":false},{"name":"Cynthia Guzzo","is_ca":false},{"name":"Shu Li","is_ca":false},{"name":"Lisa T. Dooley","is_ca":false},{"name":"Cynthia M. Arnold","is_ca":false},{"name":"Alice B. Gottlieb","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01481883019480398,"gpt":0.280921689709543,"spread":0.266102859514739,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002993503,0.0002291449,0.002068597,0.0002456516,0.00004380436,0.000003676924,0.0005295082,0.0001597241,0.00002008834],"category_scores_gemma":[0.00007763448,0.0001212448,0.000547135,0.0002820694,0.0007924882,0.00004713901,0.00004745822,0.000252201,0.000005022199],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006670064,"about_ca_system_score_gemma":0.00006873803,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002627211,"about_ca_topic_score_gemma":0.00002204623,"domain_scores_codex":[0.9968705,0.001242179,0.001341999,0.0001545383,0.0001041008,0.0002867409],"domain_scores_gemma":[0.9964216,0.000816955,0.002454779,0.0002099474,0.00007694629,0.00001979929],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.4977055,0.007535662,0.3193004,0.0001372417,0.006566046,0.0001060669,0.01651214,0.001516869,0.0930009,0.006374035,0.03202676,0.01921834],"study_design_scores_gemma":[0.3590993,0.003199922,0.2122748,0.0005547429,0.00255534,0.004191047,0.004995878,0.0001073501,0.3912501,0.002008832,0.0191185,0.0006442232],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9930457,0.001871578,0.000047236,0.004167352,0.0001967397,0.0004435978,0.00003579288,0.000004006926,0.0001879853],"genre_scores_gemma":[0.998795,0.000528372,0.0002308052,0.0002475803,0.00002781944,0.00002076554,0.000003028444,0.00001239722,0.0001342399],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2982492,"threshold_uncertainty_score":0.494422,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2606035821","doi":"10.1056/nejmoa1607017","title":"Risankizumab versus Ustekinumab for Moderate-to-Severe Plaque Psoriasis","year":2017,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":511,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; Probity Medical Research","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Internal medicine; Interleukin 23; Gastroenterology; Adverse effect; Interleukin 17; Dermatology; Cytokine; Disease","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Andrew Blauvelt","is_ca":true},{"name":"Michael Bukhalo","is_ca":true},{"name":"Melinda Gooderham","is_ca":true},{"name":"James G. Krueger","is_ca":true},{"name":"J.‐P. Lacour","is_ca":true},{"name":"Alan Menter","is_ca":true},{"name":"Sandra Philipp","is_ca":true},{"name":"Howard Sofen","is_ca":true},{"name":"Stephen K. Tyring","is_ca":true},{"name":"B Berner","is_ca":true},{"name":"Sudha Visvanathan","is_ca":true},{"name":"Chandrasena Pamulapati","is_ca":true},{"name":"Nathan Bennett","is_ca":true},{"name":"Mary Flack","is_ca":true},{"name":"Paul Scholl","is_ca":true},{"name":"Steven J. Padula","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.04268194601443099,"gpt":0.2982235786206202,"spread":0.2555416326061892,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000583987,0.0002177876,0.0005978354,0.0001618746,0.0004151245,0.0000256152,0.0004461273,0.0001869097,0.0004898779],"category_scores_gemma":[0.0007359088,0.0001448652,0.0001416549,0.00004209678,0.0001006435,0.0001446318,0.00004065443,0.000214381,0.00005176143],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006196528,"about_ca_system_score_gemma":0.0001578444,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001397453,"about_ca_topic_score_gemma":0.0001251924,"domain_scores_codex":[0.9988694,0.00009919548,0.0004457611,0.0001856586,0.00008921199,0.0003107963],"domain_scores_gemma":[0.9983571,0.0004734792,0.0004892112,0.0003723007,0.0001831554,0.0001248207],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.05296,0.0001272577,0.001160454,0.000027424,0.001574698,0.0001214612,0.002024394,0.00007301016,0.0111935,0.0006335697,0.1076372,0.822467],"study_design_scores_gemma":[0.4258262,0.007434063,0.006757088,0.0003872034,0.001443404,0.001245101,0.0004032952,0.00001120826,0.0162675,0.001615378,0.5381968,0.0004127463],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.961514,0.004469046,0.002177855,0.01162979,0.01539081,0.0004510329,0.00006069516,0.00002816278,0.004278586],"genre_scores_gemma":[0.9922108,0.0003615245,0.0006637356,0.0001521716,0.003273308,0.000007235267,0.0000251503,0.00002198348,0.00328409],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8220543,"threshold_uncertainty_score":0.590743,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2156148414","doi":"10.1016/j.jaad.2013.12.018","title":"Patient perspectives in the management of psoriasis: Results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey","year":2014,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":511,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dalhousie University","funders":"","keywords":"Psoriasis; Medicine; Psoriatic arthritis; Dermatology; Multinational corporation; Family medicine","authors":[{"name":"Mark Lebwohl","is_ca":false},{"name":"H. Bachelez","is_ca":false},{"name":"Giampiero Girolomoni","is_ca":false},{"name":"Arthur Kavanaugh","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"C. Paul","is_ca":false},{"name":"L. Puig","is_ca":false},{"name":"Kristian Reich","is_ca":false},{"name":"P.C.M. van de Kerkhof","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01763577591121485,"gpt":0.2849447469926242,"spread":0.2673089710814093,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009629027,0.0001622543,0.0006476154,0.000140182,0.00009536313,0.000005078131,0.0004684113,0.00009986922,0.00001135922],"category_scores_gemma":[0.0002816833,0.00008824892,0.0001801589,0.0003093667,0.0004660131,0.00005389441,0.00007190568,0.0002867639,6.916061e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003763109,"about_ca_system_score_gemma":0.00005299054,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005942954,"about_ca_topic_score_gemma":0.00006467365,"domain_scores_codex":[0.9959321,0.002493465,0.001050907,0.0001719153,0.0001788449,0.0001727861],"domain_scores_gemma":[0.9945928,0.002663278,0.002406796,0.0002149065,0.0001071661,0.00001507399],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.002358724,0.001106936,0.8750436,0.0000610742,0.00259293,0.000006756938,0.005190291,0.000595885,0.001933375,0.004703584,0.0009596114,0.1054472],"study_design_scores_gemma":[0.003389521,0.0001844545,0.9906967,0.0001353492,0.0002389655,0.00006080498,0.002571652,0.00005883758,0.001844371,0.000515657,0.0002241667,0.00007951661],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9921955,0.001798882,0.00007193039,0.005231989,0.0002316822,0.0002346077,0.0001835136,0.000002566209,0.0000493493],"genre_scores_gemma":[0.9980627,0.000716888,0.0009629688,0.0001892222,0.00002590754,0.000009417242,0.00002113861,0.000007954996,0.000003816457],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1156531,"threshold_uncertainty_score":0.3598686,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2008716526","doi":"10.1016/j.jaad.2006.05.027","title":"Clinical response to adalimumab treatment in patients with moderate to severe psoriasis: Double-blind, randomized controlled trial and open-label extension study","year":2006,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":507,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research; Dalhousie University","funders":"","keywords":"Medicine; Adalimumab; Open label; Psoriasis; Randomized controlled trial; Double blind; Dermatology; Surgery; Internal medicine; Placebo; Alternative medicine; Tumor necrosis factor alpha","authors":[{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Darryl Toth","is_ca":true},{"name":"Alan Menter","is_ca":false},{"name":"Sewon Kang","is_ca":false},{"name":"Michael Heffernan","is_ca":false},{"name":"Bruce Miller","is_ca":false},{"name":"Regina Hamlin","is_ca":false},{"name":"Liberata Lim","is_ca":false},{"name":"Rebecca L. Hoffman","is_ca":false},{"name":"Martin M. Okun","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.03691857886856944,"gpt":0.3417004839563627,"spread":0.3047819050877933,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001556028,0.0003122254,0.003552194,0.0003759581,0.0001190251,0.0000197386,0.0004885694,0.0001755662,0.000007674055],"category_scores_gemma":[0.0002601653,0.0001610322,0.0002436966,0.0003378999,0.0003165122,0.0001045797,0.000175405,0.0002976007,0.000007560131],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000781554,"about_ca_system_score_gemma":0.0001856722,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001629104,"about_ca_topic_score_gemma":0.00003867209,"domain_scores_codex":[0.9924652,0.004963103,0.001792469,0.0003313477,0.0001246284,0.0003232403],"domain_scores_gemma":[0.9960924,0.001693948,0.001793629,0.0002212577,0.0001264898,0.00007224815],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9634607,0.004191141,0.02739184,0.000001793289,0.001524387,0.00002224072,0.000271337,0.00006142422,0.0004278774,0.00001521576,0.0003394236,0.002292601],"study_design_scores_gemma":[0.9391255,0.006379954,0.05215943,0.00004338896,0.001039427,0.0001848543,0.0001741903,0.00000263713,0.0005020985,0.00004111503,0.0001825234,0.0001648629],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9884652,0.0004726679,0.00001257431,0.004320266,0.0003633664,0.00632992,0.00001178314,0.000006381275,0.00001776451],"genre_scores_gemma":[0.9986963,0.00006536621,0.0003288367,0.0004481404,0.00004106808,0.0002234611,0.00000219526,0.000019391,0.0001752965],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0247676,"threshold_uncertainty_score":0.6566703,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2914164523","doi":"10.1016/j.jaad.2018.11.058","title":"Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities","year":2019,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":486,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"Janssen Pharmaceuticals; Janssen Biotech; Sandoz; Ortho Dermatologics; LEO Pharma Research Foundation; LEO Pharma; Pfizer; Incyte; Prothena; Novartis Pharmaceuticals Corporation; Dermira; Coherus Biosciences; Valeant Pharmaceuticals International; Janssen Research and Development; XBiotech; UCB; Celgene; Eli Lilly and Company; Allergan; AstraZeneca; Boehringer Ingelheim; Amgen; AbbVie; Sanofi; MedImmune; Merck; National Institutes of Health; Regeneron Pharmaceuticals; Abbott Laboratories","keywords":"Medicine; Psoriasis; Guideline; Intensive care medicine; Population; Disease management; Joint disease; Disease; Dermatology; Alternative medicine; Internal medicine; Pathology; Environmental health","authors":[{"name":"Craig A. Elmets","is_ca":false},{"name":"Craig L. Leonardi","is_ca":false},{"name":"Dawn Marie R. Davis","is_ca":false},{"name":"Joel M. Gelfand","is_ca":false},{"name":"Jason Lichten","is_ca":false},{"name":"Nehal N. Mehta","is_ca":false},{"name":"April W. Armstrong","is_ca":false},{"name":"Cody Connor","is_ca":false},{"name":"Kelly M. Cordoro","is_ca":false},{"name":"Boni E. Elewski","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Alice B. Gottlieb","is_ca":false},{"name":"Daniel H. Kaplan","is_ca":false},{"name":"Arthur Kavanaugh","is_ca":false},{"name":"Darío Kivelevitch","is_ca":false},{"name":"Matthew Kiselica","is_ca":false},{"name":"Neil J. Korman","is_ca":false},{"name":"Daniela Kroshinsky","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Henry W. Lim","is_ca":false},{"name":"Amy S. Paller","is_ca":false},{"name":"Sylvia L. Parra","is_ca":false},{"name":"Arun L. Pathy","is_ca":false},{"name":"Elizabeth Farley Prater","is_ca":false},{"name":"Reena Rupani","is_ca":false},{"name":"Michael Siegel","is_ca":false},{"name":"Benjamin K. Stoff","is_ca":false},{"name":"Bruce Strober","is_ca":true},{"name":"Emily Wong","is_ca":false},{"name":"Jashin J. Wu","is_ca":false},{"name":"Vidhya Hariharan","is_ca":false},{"name":"Alan Menter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.08175444726901368,"gpt":0.3534888795521198,"spread":0.2717344322831061,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001284176,0.0003070223,0.00252098,0.0002544177,0.00009238041,0.000003926711,0.00032036,0.0001674399,0.000003448065],"category_scores_gemma":[0.00001983038,0.0001421161,0.0004877763,0.0001700591,0.000547775,0.00003109537,0.0001032366,0.000118671,9.361826e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004472729,"about_ca_system_score_gemma":0.00009850242,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004542768,"about_ca_topic_score_gemma":0.000007704478,"domain_scores_codex":[0.9981838,0.0003188069,0.001053045,0.0001859242,0.00007193901,0.000186467],"domain_scores_gemma":[0.9963561,0.0004212148,0.002842171,0.0002073101,0.0001509041,0.000022351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0006743245,0.0001162892,0.002300842,0.00641979,0.007802445,0.000004429955,0.0005087963,0.000006063607,0.0001509323,0.0002262322,0.00117235,0.9806175],"study_design_scores_gemma":[0.003349348,0.002136394,0.006444253,0.006265784,0.02012916,0.003211363,0.00309537,7.98029e-7,0.003023743,0.00004174044,0.9519749,0.0003271131],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.03650284,0.9609606,0.00005561258,0.001027934,0.0002927452,0.0009383461,0.0002055749,0.000002807696,0.00001358131],"genre_scores_gemma":[0.01561821,0.9834244,0.0006446054,0.00005015845,0.00003814021,0.00005042432,0.00001218375,0.00002207999,0.000139795],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9802904,"threshold_uncertainty_score":0.5795327,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2996552716","doi":"10.1016/j.cell.2019.11.026","title":"Serum Amyloid A Proteins Induce Pathogenic Th17 Cells and Promote Inflammatory Disease","year":2019,"lang":"en","type":"article","venue":"Cell","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":484,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; Alberta Innovates; Damon Runyon Cancer Research Foundation; National Multiple Sclerosis Society; Howard Hughes Medical Institute","keywords":"Biology; Interleukin 17; Immunology; Inflammation; Cell biology; RAR-related orphan receptor gamma; Cytokine; Innate lymphoid cell; FOXP3; Acquired immune system; Immune system","authors":[{"name":"June‐Yong Lee","is_ca":false},{"name":"Jason A. Hall","is_ca":false},{"name":"Lina Kroehling","is_ca":false},{"name":"Lin Wu","is_ca":false},{"name":"Tariq Ahmad Najar","is_ca":false},{"name":"Henry H. Nguyen","is_ca":false},{"name":"Woan-Yu Lin","is_ca":false},{"name":"Stephen T. Yeung","is_ca":false},{"name":"Hernandez Moura Silva","is_ca":false},{"name":"Dayi Li","is_ca":false},{"name":"Ashley M. Hine","is_ca":false},{"name":"P’ng Loke","is_ca":false},{"name":"David Hudesman","is_ca":false},{"name":"J.P. Martin","is_ca":false},{"name":"Ephraim Kenigsberg","is_ca":false},{"name":"Miriam Mérad","is_ca":false},{"name":"Kamal M. Khanna","is_ca":false},{"name":"Dan R. Littman","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.007569796244783693,"gpt":0.1910738623451584,"spread":0.1835040661003748,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0001206303,0.0002201301,0.0002161851,0.00006702897,0.0001106164,0.00001783095,0.0001457512,0.0001968631,0.0005244029],"category_scores_gemma":[0.000006506022,0.0001870208,0.00008762182,0.0000731422,0.00006774286,0.00008851132,0.0000966056,0.0001484489,0.002934026],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002275857,"about_ca_system_score_gemma":0.00008969112,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007514551,"about_ca_topic_score_gemma":0.000004210769,"domain_scores_codex":[0.998934,0.0001306835,0.0001757884,0.0003831701,0.00003332429,0.0003430774],"domain_scores_gemma":[0.999395,0.0000334394,0.00008938754,0.000387514,0.00002652589,0.00006820718],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0001207951,0.0001442533,0.01143615,0.00009722686,0.00006659187,0.00003155109,0.0003084936,8.906136e-7,0.9829777,0.00002711848,0.0001961841,0.004593033],"study_design_scores_gemma":[0.002715699,0.0002183559,0.08192236,0.00004846347,0.0001634482,0.00001236256,0.00009369496,0.000003660515,0.8835936,0.000123751,0.0307172,0.0003874342],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9927227,0.004318099,0.000002855297,0.00005233549,0.0005598618,0.0008843106,0.0001163274,0.00007945409,0.001264094],"genre_scores_gemma":[0.9836257,0.0001496359,0.00005288842,0.00006753131,0.00004114729,0.00007080456,0.00005610888,0.00002625677,0.01590994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.09938414,"threshold_uncertainty_score":0.9978423,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2514982855","doi":"10.1111/jdv.14386","title":"European consensus statement on phenotypes of pustular psoriasis","year":2017,"lang":"en","type":"review","venue":"Journal of the European Academy of Dermatology and Venereology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":440,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Institute of Infection and Immunity","funders":"National Institute for Health and Care Research; European Academy of Dermatology and Venereology; Psoriasis Association","keywords":"Medicine; Psoriasis; Generalized pustular psoriasis; Dermatology; Phenotype; Pustular psoriasis; Clinical trial; Pathology; Genetics","authors":[{"name":"Alexander A. Navarini","is_ca":false},{"name":"A. David Burden","is_ca":true},{"name":"Francesca Capon","is_ca":false},{"name":"Ulrich Mrowietz","is_ca":false},{"name":"L. Puig","is_ca":false},{"name":"Sulev Kõks","is_ca":false},{"name":"Külli Kingo","is_ca":false},{"name":"Catherine Smith","is_ca":false},{"name":"Juliet N. Barker","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.0838083635548977,"gpt":0.3311105540073089,"spread":0.2473021904524112,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001394836,0.000492426,0.00264062,0.0003703775,0.0002432931,0.000006879153,0.001268925,0.0005141105,0.00004736519],"category_scores_gemma":[0.000297071,0.0002997107,0.0008096416,0.00009120658,0.001217356,0.00003738571,0.0004009254,0.001031245,0.0000879966],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002999016,"about_ca_system_score_gemma":0.0001339517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002408182,"about_ca_topic_score_gemma":7.085561e-7,"domain_scores_codex":[0.9899004,0.00740328,0.001932026,0.0003143394,0.00008228217,0.0003676809],"domain_scores_gemma":[0.993545,0.0006467829,0.005240044,0.0004337319,0.00008280909,0.0000516171],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003897252,0.0003097522,0.001171841,0.002557327,0.005495633,0.0003453556,0.0002342638,0.000002984709,0.0001995936,0.001822741,0.008185063,0.9792857],"study_design_scores_gemma":[0.001806102,0.0001292221,0.001535889,0.002837736,0.003491517,0.007474408,0.0000249519,8.188677e-8,0.0007332859,0.000161768,0.981556,0.0002490575],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.005899529,0.9864251,0.000003497194,0.0006969813,0.001529388,0.000267957,0.0000916303,0.000009357643,0.00507658],"genre_scores_gemma":[0.06064686,0.9383237,0.0000617562,0.00008518727,0.0001644088,0.000001954146,0.00001318476,0.00005827776,0.0006447153],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9790367,"threshold_uncertainty_score":0.9999455,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2114677349","doi":"10.1016/j.jaad.2008.01.006","title":"National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening","year":2008,"lang":"en","type":"review","venue":"Journal of the American Academy of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":431,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Toronto Western Hospital; University Health Network","funders":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","keywords":"Medicine; Psoriasis; Foundation (evidence); Disease; Intensive care medicine; Population; MEDLINE; Dermatology; Family medicine; Pathology; Environmental health","authors":[{"name":"Alexa B. Kimball","is_ca":false},{"name":"Dafna D. Gladman","is_ca":true},{"name":"Joel M. Gelfand","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Elizabeth J. Horn","is_ca":false},{"name":"Neil J. Korman","is_ca":false},{"name":"Gretchen Korver","is_ca":false},{"name":"Gerald G. Krueger","is_ca":false},{"name":"Bruce Strober","is_ca":false},{"name":"Mark Lebwohl","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1359285291485051,"gpt":0.4088836466374366,"spread":0.2729551174889315,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004864154,0.0003570923,0.002488015,0.0004436388,0.0003040632,0.000009426266,0.0004713864,0.0004825337,0.0000281538],"category_scores_gemma":[0.0007837544,0.0002416679,0.001095552,0.0002635761,0.001189583,0.00005655134,0.00009001738,0.0007885429,0.00001535157],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006827327,"about_ca_system_score_gemma":0.0004009666,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000006448722,"about_ca_topic_score_gemma":0.000001355269,"domain_scores_codex":[0.9958382,0.001645264,0.0018667,0.0002660817,0.0001139593,0.0002697798],"domain_scores_gemma":[0.9892855,0.005236323,0.00511365,0.0001392425,0.0001824704,0.0000427892],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003922637,0.0001414242,0.00016562,0.0002753644,0.002613547,0.000003480882,0.00005389845,8.810597e-7,0.000004984885,0.0009081106,0.052713,0.9427274],"study_design_scores_gemma":[0.001567474,0.0003223943,0.0004552464,0.00111906,0.001614602,0.007028083,0.00009687599,0.000001409375,0.00005495271,0.0002856863,0.9872458,0.000208445],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002678781,0.9850797,0.00008620774,0.008904456,0.002044083,0.0006351138,0.0004335392,0.00001656543,0.0001215515],"genre_scores_gemma":[0.001370441,0.9955011,0.002132046,0.0004376832,0.0002799316,0.00003174568,0.0000728996,0.00003350212,0.0001406529],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9425189,"threshold_uncertainty_score":0.9854929,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2892136519","doi":"10.1056/nejmoa1806382","title":"Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis","year":2018,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":414,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Queen's University; Probity Medical Research","funders":"Bristol-Myers Squibb","keywords":"Placebo; Medicine; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Gastroenterology; Clinical endpoint; Tyrosine kinase 2; Clinical trial; Pharmacology; Immunology; Pathology; Receptor; Platelet-derived growth factor receptor","authors":[{"name":"Kim Papp","is_ca":true},{"name":"Kenneth B. Gordon","is_ca":true},{"name":"Diamant Thaçi","is_ca":true},{"name":"Akimichi Morita","is_ca":true},{"name":"Melinda Gooderham","is_ca":true},{"name":"Peter Foley","is_ca":true},{"name":"Ihab Girgis","is_ca":true},{"name":"Sudeep Kundu","is_ca":true},{"name":"Subhashis Banerjee","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02193395392893607,"gpt":0.2897631125167306,"spread":0.2678291585877946,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007866017,0.0001273463,0.0004855213,0.0003245051,0.00003846741,0.000001791996,0.00006537294,0.0001258472,0.0004250513],"category_scores_gemma":[0.0003698087,0.0000844897,0.00007105043,0.0002657251,0.00017795,0.00007621119,0.00001084659,0.0001814845,0.00001315706],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004114284,"about_ca_system_score_gemma":0.0001185615,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001256074,"about_ca_topic_score_gemma":0.00009126941,"domain_scores_codex":[0.9988173,0.0002494863,0.0005858805,0.0001074911,0.00007583742,0.000164037],"domain_scores_gemma":[0.9990304,0.0002045307,0.0004112814,0.0001006957,0.0002097274,0.00004341777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1544443,0.001302389,0.0006119278,0.00001217007,0.0003219906,0.0001164753,0.002974687,0.000001149164,0.3892411,0.0001351048,0.009274225,0.4415645],"study_design_scores_gemma":[0.7143036,0.01964415,0.0009642267,0.0002317567,0.0002778579,0.0003358726,0.0001413608,8.366982e-7,0.2519875,0.0005586407,0.01147229,0.00008193759],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939419,0.002122078,0.0001387805,0.0007884546,0.002102189,0.0001503102,0.000008467098,0.00000564454,0.0007421699],"genre_scores_gemma":[0.9965216,0.0003156798,0.00008172391,0.00006091777,0.002719247,0.00000172317,0.00002109458,0.000007902736,0.0002701198],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5598593,"threshold_uncertainty_score":0.4654014,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2605632483","doi":"","title":"Diagnosis and management of psoriasis.","year":2017,"lang":"en","type":"review","venue":"PubMed","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":412,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Medicine; Psoriasis; Psychosocial; Disease; Intensive care medicine; Acitretin; MEDLINE; Observational study; Dermatology; Psychological intervention; Referral; Clinical trial; Physical therapy; Internal medicine; Psychiatry; Family medicine","authors":[{"name":"Whan B. Kim","is_ca":true},{"name":"Dana Jerome","is_ca":true},{"name":"Jensen Yeung","is_ca":true}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1097961194219535,"gpt":0.3045903520668061,"spread":0.1947942326448526,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002647682,0.0003211536,0.001359519,0.0001400505,0.0001206013,0.00001672392,0.0003390078,0.0003975372,0.00005367864],"category_scores_gemma":[0.00002312349,0.0002423251,0.0003398418,0.0000605085,0.0001364975,0.00004157248,0.0001851078,0.000107191,0.0000954736],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003105365,"about_ca_system_score_gemma":0.00001543102,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001499896,"about_ca_topic_score_gemma":0.00000359196,"domain_scores_codex":[0.9987254,0.0001543415,0.0003830924,0.000370658,0.00002832284,0.0003381949],"domain_scores_gemma":[0.9988061,0.0001267518,0.000447816,0.0005738965,0.00001694278,0.00002847169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00000846479,0.00006986726,0.00006700124,0.007162007,0.002381371,0.00001358169,0.000008252289,1.56741e-9,1.500317e-8,0.0001986561,0.001209208,0.9888816],"study_design_scores_gemma":[0.0005000859,0.00001129572,0.004912174,0.001571865,0.004214763,0.00002030284,0.000003688285,7.648608e-10,0.00001192411,0.00002014837,0.9885301,0.0002036761],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00003611132,0.9928288,3.624645e-7,0.000012127,0.00111691,0.001608079,0.0001623396,0.00002746177,0.00420777],"genre_scores_gemma":[0.00007237124,0.9839486,0.00002261214,0.000003846869,0.00004432161,0.009407184,0.000168519,0.00002698245,0.006305549],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9886779,"threshold_uncertainty_score":0.9881732,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1661616496","doi":"10.1111/bjd.12214","title":"Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up","year":2013,"lang":"en","type":"review","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":410,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia; Probity Medical Research","funders":"","keywords":"Ustekinumab; Medicine; Mace; Adverse effect; Psoriasis; Population; Internal medicine; Dermatology; Disease; Environmental health","authors":[{"name":"Kim Papp","is_ca":true},{"name":"C.E.M. Griffiths","is_ca":false},{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Mark Lebwohl","is_ca":false},{"name":"Philippe Szapary","is_ca":false},{"name":"Yasmine Wasfi","is_ca":false},{"name":"Daphne Chan","is_ca":false},{"name":"M.-C. Hsu","is_ca":false},{"name":"Vincent Ho","is_ca":true},{"name":"Pierre‐Dominique Ghislain","is_ca":false},{"name":"Bruce Strober","is_ca":true},{"name":"Kristian Reich","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.02396324823692888,"gpt":0.2498224002245274,"spread":0.2258591519875985,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001815055,0.0004243919,0.003513038,0.0005002999,0.00005162515,0.00001712372,0.0006030554,0.0008958442,0.0001684643],"category_scores_gemma":[0.0001772381,0.0004008566,0.0005399043,0.00030274,0.0001604852,0.0001575788,0.0001151314,0.0005954527,0.00006404758],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0000969229,"about_ca_system_score_gemma":0.0005046916,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002558685,"about_ca_topic_score_gemma":0.0002548235,"domain_scores_codex":[0.9957407,0.000867892,0.002411804,0.0004016082,0.0001366999,0.0004413119],"domain_scores_gemma":[0.9964014,0.0004796716,0.002313547,0.000358328,0.0003772514,0.00006984122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.004833282,0.0005575969,0.006734433,0.0008403039,0.002381132,0.001007117,0.0001890175,0.000004334853,0.000003322279,0.000005025147,0.001247699,0.9821967],"study_design_scores_gemma":[0.1815219,0.003733712,0.4395398,0.1385739,0.01417061,0.05902403,0.0002045057,7.214443e-7,0.0005944659,0.0001183739,0.15906,0.003458077],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.2850086,0.7119841,0.00001888921,0.00001078747,0.0009504875,0.0005741097,0.001391178,0.000006488035,0.00005541639],"genre_scores_gemma":[0.1104662,0.8878542,0.0002901513,0.00001495898,0.00004894174,0.0000248931,0.001052893,0.00006084839,0.00018685],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9787387,"threshold_uncertainty_score":0.9998443,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2618122943","doi":"10.1038/ncomms15382","title":"Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants","year":2017,"lang":"en","type":"review","venue":"Nature Communications","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":400,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Memorial University of Newfoundland; Toronto Western Hospital; University of Toronto","funders":"National Center for Research Resources; European Regional Development Fund; National Institute of Arthritis and Musculoskeletal and Skin Diseases; Medical Research Council; National Institutes of Health; Tartu Ülikool; Heinz Nixdorf Stiftung; Deutsche Forschungsgemeinschaft; Exzellenzclusters Entzündungsforschung; National Research Foundation; King's College London; Psoriasis Association; National Human Genome Research Institute; Wellcome Trust; National Psoriasis Foundation; Helene Morgan Babcock and Alfred Babcock Memorial Scholarship Trust; A. Alfred Taubman Medical Research Institute; Dermatology Foundation; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Arthritis National Research Foundation; U.S. Department of Veterans Affairs; Foundation for the National Institutes of Health","keywords":"Psoriasis; Genome-wide association study; Genetic architecture; Heritability; Genetics; Genetic association; Biology; Meta-analysis; Computational biology; Medicine; Quantitative trait locus; Single-nucleotide polymorphism; Immunology; Gene; Genotype; Internal medicine","authors":[{"name":"Lam C. Tsoi","is_ca":false},{"name":"Philip E. Stuart","is_ca":false},{"name":"Chao Tian","is_ca":false},{"name":"Jóhann E. Guðjónsson","is_ca":false},{"name":"Sayantan Das","is_ca":false},{"name":"Matthew Zawistowski","is_ca":false},{"name":"Eva Ellinghaus","is_ca":false},{"name":"Vinod Chandran","is_ca":true},{"name":"Nick Dand","is_ca":false},{"name":"Kristina Callis Duffin","is_ca":false},{"name":"Charlotta Enerbäck","is_ca":false},{"name":"Tõnu Esko","is_ca":false},{"name":"André Franke","is_ca":false},{"name":"Dafna D. Gladman","is_ca":true},{"name":"Per Hoffmann","is_ca":false},{"name":"Külli Kingo","is_ca":false},{"name":"Sulev Kõks","is_ca":false},{"name":"Gerald G. Krueger","is_ca":false},{"name":"Henry W. Lim","is_ca":false},{"name":"Andres Metspalu","is_ca":false},{"name":"Ulrich Mrowietz","is_ca":false},{"name":"Sören Mucha","is_ca":false},{"name":"Proton Rahman","is_ca":true},{"name":"André Reis","is_ca":false},{"name":"Trilokraj Tejasvi","is_ca":false},{"name":"Richard C. Trembath","is_ca":false},{"name":"John J. Voorhees","is_ca":false},{"name":"Stephan Weidinger","is_ca":false},{"name":"Michael Weichenthal","is_ca":false},{"name":"Xiaoquan Wen","is_ca":false},{"name":"Nicholas Eriksson","is_ca":false},{"name":"Hyun Min Kang","is_ca":false},{"name":"David A. Hinds","is_ca":false},{"name":"Rajan P. Nair","is_ca":false},{"name":"Gonçalo R. Abecasis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.1216175602596136,"gpt":0.3777229581284424,"spread":0.2561053978688288,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0007656558,0.0008034122,0.005204488,0.0006084388,0.001719995,0.0001139701,0.003798997,0.003037099,0.0003231701],"category_scores_gemma":[0.0003677703,0.0005984684,0.006008358,0.0006117306,0.0002091171,0.00007472791,0.0006579704,0.001784216,0.0001855388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001124382,"about_ca_system_score_gemma":0.000196065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00003214295,"about_ca_topic_score_gemma":0.002917391,"domain_scores_codex":[0.995683,0.00197668,0.0009350031,0.00071682,0.00008325969,0.0006052002],"domain_scores_gemma":[0.9902751,0.001806267,0.00158365,0.00604302,0.000235509,0.00005646822],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00002839807,0.0008838004,0.00005497939,0.0005411809,0.5743361,0.000002603381,0.000284169,3.915403e-7,0.00001222097,0.0003434084,0.003257108,0.4202556],"study_design_scores_gemma":[0.0003674319,0.00002679204,0.0004081175,0.00009462891,0.3817073,0.000009910448,0.000006461885,9.07437e-7,0.000002837247,0.00004731633,0.6169998,0.000328436],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00001323705,0.9814265,0.00008033141,0.0004049521,0.0006412606,0.001658073,0.01514222,0.0001277914,0.0005055763],"genre_scores_gemma":[0.001277107,0.958016,0.001435703,0.0001109618,0.00006935553,0.00193491,0.03352802,0.0000884271,0.00353946],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.6137427,"threshold_uncertainty_score":0.9996467,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2034585843","doi":"10.1001/jama.290.23.3073","title":"Efalizumab for Patients With Moderate to Severe Plaque Psoriasis","year":2003,"lang":"en","type":"article","venue":"JAMA","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":397,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Efalizumab; Medicine; Psoriasis; Psoriasis Area and Severity Index; Dermatology Life Quality Index; Placebo; Adverse effect; Severity of illness; Internal medicine; Dermatology; Plaque psoriasis; Randomized controlled trial; Visual analogue scale; Surgery; Pathology","authors":[{"name":"Kenneth B. Gordon","is_ca":false},{"name":"Kim Papp","is_ca":true},{"name":"Tiffani K. Hamilton","is_ca":false},{"name":"Patricia A. Walicke","is_ca":false},{"name":"Wolfgang Dummer","is_ca":false},{"name":"Nicole Li","is_ca":false},{"name":"Brian W. Bresnahan","is_ca":false},{"name":"Alan Menter","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01132498776174481,"gpt":0.2192114849151484,"spread":0.2078864971534036,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007667108,0.0001794382,0.0002163117,0.00006477591,0.0001764401,0.00002205365,0.0000976247,0.0001868347,0.0002316766],"category_scores_gemma":[0.00007043295,0.0001347197,0.00006586137,0.0001041457,0.00002151917,0.00008540535,0.00001432098,0.0000605313,0.0003581655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004319854,"about_ca_system_score_gemma":0.00004458054,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001551563,"about_ca_topic_score_gemma":0.00002089833,"domain_scores_codex":[0.9991326,0.0000903329,0.0001409596,0.0002852345,0.00002924931,0.0003216517],"domain_scores_gemma":[0.9994726,0.000101132,0.00005082238,0.0002248882,0.00011616,0.00003434987],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.03674488,0.003562096,0.1745169,0.0001627185,0.004382305,0.00003148356,0.004895294,0.0003696054,0.007705823,0.02518145,0.1639924,0.578455],"study_design_scores_gemma":[0.06818766,0.003838307,0.08247609,0.0001161892,0.0006532359,0.00005893979,0.0004302379,0.000005653665,0.1050632,0.00161393,0.7360939,0.001462666],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9939707,0.0001888507,0.0006028115,0.0002104012,0.0006259626,0.0006682689,0.0002463991,0.00006048508,0.003426147],"genre_scores_gemma":[0.9928167,0.000009882297,0.001501559,0.0003348441,0.00003613038,0.0002134143,0.0002422981,0.00002616094,0.004818985],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5769923,"threshold_uncertainty_score":0.5493709,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2132938540","doi":"10.4049/jimmunol.175.1.404","title":"Role of IL-17A, IL-17F, and the IL-17 Receptor in Regulating Growth-Related Oncogene-α and Granulocyte Colony-Stimulating Factor in Bronchial Epithelium: Implications for Airway Inflammation in Cystic Fibrosis","year":2005,"lang":"en","type":"article","venue":"The Journal of Immunology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":395,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Women's Health Research Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Cystic fibrosis; Granulocyte colony-stimulating factor receptor; Inflammation; Epithelium; Respiratory epithelium; Granulocyte colony-stimulating factor; Interleukin 17; Immunology; Granulocyte; Medicine; Airway; Receptor; Cancer research; Biology; Internal medicine; Pathology","authors":[{"name":"Florencia McAllister","is_ca":false},{"name":"Adam C. Henry","is_ca":false},{"name":"James L. Kreindler","is_ca":false},{"name":"Patricia J. Dubin","is_ca":false},{"name":"Lauren Ulrich","is_ca":false},{"name":"Chad Steele","is_ca":false},{"name":"Jonathan D. Finder","is_ca":false},{"name":"Joseph M. Pilewski","is_ca":false},{"name":"Beatriz M. Carreno","is_ca":true},{"name":"Samuel J. Goldman","is_ca":true},{"name":"Jaana Pirhonen","is_ca":false},{"name":"Jay K. Kolls","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.009079376718189737,"gpt":0.2303342768316972,"spread":0.2212549001135075,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001212008,0.0001964898,0.0005669812,0.0003159162,0.0001708076,0.000009563874,0.0002312109,0.0002926385,0.00002759104],"category_scores_gemma":[0.0003986519,0.0001299924,0.00009126859,0.0002518601,0.0003720817,0.0001593014,0.00007545697,0.000347599,0.000003225992],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001231239,"about_ca_system_score_gemma":0.00007283298,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002466739,"about_ca_topic_score_gemma":0.0005382539,"domain_scores_codex":[0.9976201,0.0008302301,0.001047725,0.000159927,0.00003723539,0.0003047973],"domain_scores_gemma":[0.9969743,0.001956359,0.0007548021,0.0001872397,0.0001139333,0.00001339002],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.003723208,0.0000905129,0.03058212,0.00001692579,0.0002406149,3.898901e-7,0.005745891,0.0006279731,0.8666354,0.0006991233,0.00001276693,0.09162511],"study_design_scores_gemma":[0.02636908,0.001192229,0.7846121,0.0003488841,0.000349606,0.0003165241,0.001715485,0.000569329,0.1780927,0.005029555,0.001045247,0.0003592815],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9867692,0.01070912,0.00004465304,0.001620983,0.0001332282,0.0005855191,0.00009166592,0.00000744525,0.00003816052],"genre_scores_gemma":[0.9980636,0.001292745,0.0004362992,0.00001841248,0.00003905705,0.00004739643,0.00002387179,0.00001621934,0.00006242045],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7540299,"threshold_uncertainty_score":0.5300936,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2138647255","doi":"10.1016/s0140-6736(14)62113-9","title":"Tofacitinib versus etanercept or placebo in moderate-to-severe chronic plaque psoriasis: a phase 3 randomised non-inferiority trial","year":2015,"lang":"en","type":"article","venue":"The Lancet","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":394,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Etanercept; Tofacitinib; Placebo; Psoriasis; Internal medicine; Psoriasis Area and Severity Index; Plaque psoriasis; Janus kinase inhibitor; Population; Randomized controlled trial; Surgery; Dermatology; Rheumatoid arthritis","authors":[{"name":"H. Bachelez","is_ca":false},{"name":"P.C.M. van de Kerkhof","is_ca":false},{"name":"Robert Strohal","is_ca":false},{"name":"А. А. Кубанов","is_ca":false},{"name":"Fernando Valenzuela","is_ca":true},{"name":"Joo‐Heung Lee","is_ca":false},{"name":"V. V. Yakusevich","is_ca":false},{"name":"Sergio Chimenti","is_ca":false},{"name":"Jocelyne Papacharalambous","is_ca":false},{"name":"James Proulx","is_ca":false},{"name":"Pankaj Gupta","is_ca":false},{"name":"Huaming Tan","is_ca":false},{"name":"Margaret Tawadrous","is_ca":false},{"name":"Hernán Valdez","is_ca":false},{"name":"Robert Wołk","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.07837364539587272,"gpt":0.324495817594725,"spread":0.2461221721988522,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000883191,0.0003073142,0.0008820242,0.00008798633,0.0001474883,0.00003907217,0.0004546049,0.0002869068,0.0006318605],"category_scores_gemma":[0.0003015525,0.0001933983,0.0001281493,0.0002371365,0.00008793283,0.00009696746,0.00008575715,0.0003052508,0.0009438564],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002063502,"about_ca_system_score_gemma":0.0004143248,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001600439,"about_ca_topic_score_gemma":0.0007287245,"domain_scores_codex":[0.9979686,0.000596897,0.000378958,0.0003762316,0.0000720273,0.0006073611],"domain_scores_gemma":[0.9986817,0.0004815136,0.0001108366,0.0006064395,0.00004875757,0.00007077777],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9699939,0.0002882947,0.00006524039,0.0000120269,0.0003312616,0.00003887027,0.001786543,0.0001356956,0.002866484,0.00005149778,0.01228023,0.01214994],"study_design_scores_gemma":[0.9570472,0.001898997,0.0001110985,0.00004128885,0.0001876127,0.00002900682,0.0003711279,0.00007221795,0.007665079,0.00007625255,0.03216549,0.0003345984],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9903549,0.000606904,0.00007621714,0.000866037,0.002788353,0.001924178,0.0002814583,0.0001031895,0.002998774],"genre_scores_gemma":[0.9959075,0.0001426012,0.00007786611,0.0002055925,0.001004099,0.0005685528,0.0001978429,0.0000258432,0.001870056],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01988525,"threshold_uncertainty_score":0.999834,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2053127888","doi":"10.1056/nejmoa1315231","title":"Brodalumab, an Anti-IL17RA Monoclonal Antibody, in Psoriatic Arthritis","year":2014,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":392,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Université Laval","funders":"Amgen","keywords":"Medicine; Psoriatic arthritis; Monoclonal antibody; Monoclonal; Ixekizumab; Immunology; Arthritis; Antibody; Dermatology; Secukinumab","authors":[{"name":"Philip J. Mease","is_ca":false},{"name":"Mark C. Genovese","is_ca":false},{"name":"Maria Greenwald","is_ca":false},{"name":"Christopher T. Ritchlin","is_ca":false},{"name":"André Beaulieu","is_ca":true},{"name":"Atul Deodhar","is_ca":false},{"name":"Richard Newmark","is_ca":false},{"name":"JingYuan Feng","is_ca":false},{"name":"Ngozi Erondu","is_ca":false},{"name":"Ajay Nirula","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01403969140501073,"gpt":0.2641910178317347,"spread":0.2501513264267239,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001114163,0.000181896,0.0006203738,0.0002789665,0.0000623864,0.000007157838,0.0002008395,0.0001483284,0.0006306386],"category_scores_gemma":[0.0002631429,0.0001260149,0.0000725572,0.0001530341,0.0001081369,0.0001389037,0.00001631792,0.0002980999,0.00004279008],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002551016,"about_ca_system_score_gemma":0.00008840517,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001755298,"about_ca_topic_score_gemma":0.0001253332,"domain_scores_codex":[0.9984541,0.0004166124,0.0005936263,0.0001627141,0.00009587793,0.0002770806],"domain_scores_gemma":[0.9991041,0.0002490292,0.0002910798,0.0001798817,0.00008109002,0.00009485376],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.0006047917,0.0001936191,0.03881032,0.000009701283,0.0001814245,0.0001482772,0.001388881,0.00002251057,0.06864411,0.0004729477,0.00204499,0.8874784],"study_design_scores_gemma":[0.2320949,0.009012009,0.5794929,0.001123177,0.0004298197,0.005667735,0.0004619849,0.00003517942,0.01075436,0.004516845,0.1558752,0.0005357878],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.98588,0.009458939,0.000329107,0.001507046,0.002076227,0.00007454926,0.0000037898,0.00001320049,0.0006571245],"genre_scores_gemma":[0.9960961,0.001711052,0.000237361,0.0002198842,0.001458881,8.750152e-7,0.00003872165,0.00001398303,0.0002230974],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.8869426,"threshold_uncertainty_score":0.690505,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2168503185","doi":"10.1056/nejmoa066886","title":"Etanercept Treatment for Children and Adolescents with Plaque Psoriasis","year":2008,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":388,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Nexus Clinical Research (Canada); Dalhousie University","funders":"National Psoriasis Foundation; Amgen","keywords":"Etanercept; Medicine; Psoriasis; Plaque psoriasis; Dermatology; Tumor necrosis factor alpha; Internal medicine","authors":[{"name":"Amy S. Paller","is_ca":false},{"name":"Elaine C. Siegfried","is_ca":false},{"name":"Richard G. Langley","is_ca":true},{"name":"Alice B. Gottlieb","is_ca":false},{"name":"David M. Pariser","is_ca":false},{"name":"Ian Landells","is_ca":true},{"name":"Adelaide A. Hebert","is_ca":false},{"name":"Lawrence F. Eichenfield","is_ca":false},{"name":"Vaishali Patel","is_ca":false},{"name":"Kara Creamer","is_ca":false},{"name":"Angelika Jahreis","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01799847982952313,"gpt":0.2390666548705623,"spread":0.2210681750410392,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001550653,0.0001776498,0.000439479,0.000117157,0.0001212061,0.000002473525,0.00007668086,0.00009431491,0.00007151859],"category_scores_gemma":[0.00003321637,0.00009365335,0.00005998419,0.00005802665,0.0001346784,0.00005042497,0.000006457464,0.00009343899,0.000005017114],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003334934,"about_ca_system_score_gemma":0.00008575407,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001003818,"about_ca_topic_score_gemma":0.00004418954,"domain_scores_codex":[0.9992815,0.00007693568,0.0002704578,0.0001325905,0.00005304029,0.0001854862],"domain_scores_gemma":[0.9994583,0.00009545502,0.0001968113,0.0001007546,0.00007023938,0.00007849104],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.01169085,0.0003877722,0.239246,0.0000202118,0.001807137,0.0001905355,0.004577378,0.000009106404,0.01096922,0.00004814686,0.0122072,0.7188464],"study_design_scores_gemma":[0.3466522,0.01735231,0.5581316,0.0006052352,0.001820676,0.02216045,0.0002196427,8.437995e-7,0.01090606,0.0001166664,0.04171056,0.0003238145],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9909685,0.006987577,0.0002542151,0.001019902,0.0004670741,0.0002089149,0.00001519565,0.00001032297,0.00006826521],"genre_scores_gemma":[0.9944761,0.003163725,0.000273665,0.00008985581,0.001070791,0.000003351397,0.00003266564,0.00001352048,0.0008763479],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7185226,"threshold_uncertainty_score":0.3819073,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2019217317","doi":"10.1046/j.1523-1747.2003.12040.x","title":"Risk of Malignancies in Psoriasis Patients Treated with Cyclosporine: a 5 y Cohort Study","year":2003,"lang":"en","type":"article","venue":"Journal of Investigative Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":385,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Psoriasis; Skin cancer; Incidence (geometry); Population; Prospective cohort study; Internal medicine; Dermatology; Cohort; Basal cell carcinoma; Cohort study; Cancer; Surgery; Gastroenterology; Basal cell","authors":[{"name":"C. Paul","is_ca":false},{"name":"Vincent Ho","is_ca":true},{"name":"Claire McGeown","is_ca":false},{"name":"Enno Christophers","is_ca":false},{"name":"Birgit Schmidtmann","is_ca":false},{"name":"Jean-Claude Guillaume","is_ca":false},{"name":"Véronique Lamarque","is_ca":false},{"name":"Louis Dubertret","is_ca":false}],"retraction":null,"screen_n_in":null,"score":{"opus":0.01134483080681904,"gpt":0.2211599671607557,"spread":0.2098151363539367,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000374344,0.0002516873,0.0009034526,0.0003794906,0.00007015745,0.000004288185,0.0001707566,0.0001792827,0.00006574578],"category_scores_gemma":[0.0005567293,0.0001731974,0.0001117321,0.0004181899,0.0004223605,0.0001303136,0.00001940564,0.0002762974,0.00001538389],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00005911344,"about_ca_system_score_gemma":0.0001789025,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001318382,"about_ca_topic_score_gemma":0.0001397683,"domain_scores_codex":[0.9972317,0.001348562,0.0008456484,0.0002047997,0.00008795205,0.0002813715],"domain_scores_gemma":[0.9978675,0.0003117514,0.001148098,0.0001943807,0.0004310586,0.00004726286],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004349465,0.001090614,0.9901667,0.00001116901,0.001351011,0.0001590102,0.001397947,0.00001073296,0.004797784,0.0001757814,0.0002429591,0.0001613648],"study_design_scores_gemma":[0.006069473,0.001061719,0.7765671,0.00004303329,0.0004503155,0.0003113609,0.0009388158,1.559693e-7,0.2140715,0.0001787149,0.0001805519,0.0001273144],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9983057,0.0006107322,0.000006476731,0.00003850755,0.0002135599,0.0004177046,0.0000280581,0.000008268677,0.0003710177],"genre_scores_gemma":[0.9994893,0.0001020492,0.0002492573,0.00003209147,0.000007253031,0.00002270313,0.00001348201,0.00001565106,0.00006821986],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2135996,"threshold_uncertainty_score":0.7062783,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}